US20080183036A1 - Systems and methods for unobstructed visualization and ablation - Google Patents
Systems and methods for unobstructed visualization and ablation Download PDFInfo
- Publication number
- US20080183036A1 US20080183036A1 US11/959,158 US95915807A US2008183036A1 US 20080183036 A1 US20080183036 A1 US 20080183036A1 US 95915807 A US95915807 A US 95915807A US 2008183036 A1 US2008183036 A1 US 2008183036A1
- Authority
- US
- United States
- Prior art keywords
- anchor
- tissue
- barrier
- membrane
- open area
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/313—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for introducing through surgical openings, e.g. laparoscopes
- A61B1/3137—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for introducing through surgical openings, e.g. laparoscopes for examination of the interior of blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/00064—Constructional details of the endoscope body
- A61B1/00071—Insertion part of the endoscope body
- A61B1/0008—Insertion part of the endoscope body characterised by distal tip features
- A61B1/00085—Baskets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/00064—Constructional details of the endoscope body
- A61B1/00071—Insertion part of the endoscope body
- A61B1/0008—Insertion part of the endoscope body characterised by distal tip features
- A61B1/00089—Hoods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/012—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor characterised by internal passages or accessories therefor
- A61B1/018—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor characterised by internal passages or accessories therefor for receiving instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/12036—Type of occlusion partial occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/1204—Type of occlusion temporary occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12136—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/005—Flexible endoscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
- A61B2018/00357—Endocardium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00577—Ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00982—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body combined with or comprising means for visual or photographic inspections inside the body, e.g. endoscopes
Definitions
- the present invention relates generally to medical devices used for accessing, visualizing, and/or treating regions of tissue within a body. More particularly, the present invention relates to methods and apparatus for intravascularly accessing, visualizing, and/or treating tissue regions at or around the ostia of the pulmonary veins of the heart, without obstructing blood flow from the pulmonary vein.
- ultrasound devices have been used to produce images from within a body in vivo.
- Ultrasound has been used both with and without contrast agents, which typically enhance ultrasound-derived images.
- catheters or probes having position sensors deployed within the body lumen such as the interior of a cardiac chamber.
- positional sensors are typically used to determine the movement of a cardiac tissue surface or the electrical activity within the cardiac tissue. When a sufficient number of points have been sampled by the sensors, a “map” of the cardiac tissue may be generated.
- Another conventional device utilizes an inflatable balloon which is typically introduced intravascularly in a deflated state and then inflated against the tissue region to be examined. Imaging is typically accomplished by an optical fiber or other apparatus such as electronic chips for viewing the tissue through the membrane(s) of the inflated balloon. Moreover, the balloon must generally be inflated for imaging.
- Other conventional balloons utilize a cavity or depression formed at a distal end of the inflated balloon. This cavity or depression is pressed against the tissue to be examined and is flushed with a clear fluid to provide a clear pathway through the blood.
- such imaging balloons have many inherent disadvantages. For instance, such balloons generally require that the balloon be inflated to a relatively large size which may undesirably displace surrounding tissue and interfere with fine positioning of the imaging system against the tissue. Moreover, the working area created by such inflatable balloons are generally cramped and limited in size. Furthermore, inflated balloons may be susceptible to pressure changes in the surrounding fluid. For example, if the environment surrounding the inflated balloon undergoes pressure changes, e.g., during systolic and diastolic pressure cycles in a beating heart, the constant pressure change may affect the inflated balloon volume and its positioning to produce unsteady or undesirable conditions for optimal tissue imaging.
- these types of imaging modalities are generally unable to provide desirable images useful for sufficient diagnosis and therapy of the endoluminal structure, due in part to factors such as dynamic forces generated by the natural movement of the heart.
- anatomic structures within the body can occlude or obstruct the image acquisition process.
- the presence and movement of opaque bodily fluids such as blood generally make in vivo imaging of tissue regions within the heart difficult.
- CT computed tomography
- MRI magnetic resonance imaging
- fluoroscopic imaging is widely used to identify anatomic landmarks within the heart and other regions of the body.
- fluoroscopy fails to provide an accurate image of the tissue quality or surface and also fails to provide for instrumentation for performing tissue manipulation or other therapeutic procedures upon the visualized tissue regions.
- fluoroscopy provides a shadow of the intervening tissue onto a plate or sensor when it may be desirable to view the intraluminal surface of the tissue to diagnose pathologies or to perform some form of therapy on it.
- the conventional imaging systems lack the capability to provide therapeutic treatments or are difficult to manipulate in providing effective therapies.
- the treatment in a patient's heart for atrial fibrillation is generally made difficult by a number of factors, such as visualization of the target tissue, access to the target tissue, and instrument articulation and management, amongst others.
- tissue imaging system which is able to provide real-time in vivo access to and images of tissue regions within body lumens such as the heart through opaque media such as blood and which also provides instruments for therapeutic procedures such as ablation of the ostia around the pulmonary veins are desirable.
- tissue imaging and manipulation apparatus that may be utilized for procedures within a body lumen, such as the heart, in which visualization of the surrounding tissue is made difficult, if not impossible, by medium contained within the lumen such as blood, is described below.
- a tissue imaging and manipulation apparatus comprises an optional delivery catheter or sheath through which a deployment catheter and imaging hood may be advanced for placement against or adjacent to the tissue to be imaged.
- the deployment catheter may define a fluid delivery lumen therethrough as well as an imaging lumen within which an optical imaging fiber or electronic imaging assembly may be disposed for imaging tissue.
- the imaging hood When deployed, the imaging hood may be expanded into any number of shapes, e.g., cylindrical, conical, semi-spherical, etc., provided that an open area or field is defined by the imaging hood.
- the open area is the area within which the tissue region of interest may be imaged and which is also defined in part by the contacted tissue region as well.
- the imaging hood may also define an atraumatic contact lip or edge for placement or abutment, against the tissue region of interest.
- the distal end of the deployment catheter or separate manipulatable catheters may be articulated through various controlling mechanisms such as push-pull wires manually or via computer control
- the deployment catheter may also be stabilized relative to the tissue surface through various methods. For instance, inflatable stabilizing balloons positioned along a length of the catheter may be utilized, or tissue engagement anchors may be passed through or along the deployment catheter for temporary engagement of the underlying tissue.
- fluid may be pumped at a positive pressure through the fluid delivery lumen until the fluid fills the open, area completely and displaces any blood from within the open area.
- the fluid may comprise any biocompatible fluid, e.g., saline, water, plasma, FluorinertTM, etc., which is sufficiently transparent to allow for relatively undistorted visualization through the fluid.
- the fluid may be pumped continuously or intermittently to allow for image capture by an optional processor which may be in communication with the assembly.
- the imaging hood may be formed into any number of configurations and the imaging assembly may also be utilized with any number of therapeutic tools, such as tissue ablation instruments, which may be deployed through the deployment catheter.
- tissue ablation instruments such as tissue ablation instruments
- One particular variation may employ an imaging hood having a tissue anchor deployable therethrough and into a portion of a body lumen such as the pulmonary vein. Once the anchor has been temporarily deployed and secured within the pulmonary vein, the hood and ablation instrument may be articulated around a circumference of the vein ostium or several ostia where the tissue may be ablated in a controlled and consistent manner to electrically isolate the tissue such that a conduction block is created.
- the imaging hood While the imaging hood is moved around the tissue with the anchor deployed and secured distally within the pulmonary vein, the imaging hood may be articulated such that blood flow through the pulmonary vein is unobstructed or uninhibited by the hood.
- the tissue surrounding the ostium may be visualized via the imaging hood prior to, during, or after the ablation to ensure that the appropriate tissue is suitably ablated for treating conditions such as atrial fibrillation.
- the distally located anchor which secures a relative position of the imaging hood with respect to the tissue may be maintained until the procedure is completed. After completion, the anchor may be at least partially withdrawn into the imaging hood or reconfigured into a low-profile shape to disengage the tissue and allow the imaging hood to be removed or repositioned in the patient body.
- FIG. 1A shows a side view of one variation of a tissue imaging apparatus during deployment from a sheath or delivery catheter.
- FIG. 1B shows the deployed tissue imaging apparatus of FIG. 1A having an optionally expandable hood or sheath attached to an imaging and/or diagnostic catheter.
- FIG. 1C shows an end view of a deployed imaging apparatus.
- FIGS. 1D to 1F show the apparatus of FIGS. 1A to 1C with an additional lumen, e.g., for passage of a guidewire therethrough.
- FIGS. 2A and 2B show one example of a deployed tissue imager positioned against or adjacent to the tissue to be imaged and a flow of fluid, such as saline, displacing blood from within the expandable hood.
- a flow of fluid such as saline
- FIG. 3A shows an articulatable imaging assembly which may be manipulated via push-pull wires or by computer control.
- FIGS. 3B and 3C show steerable instruments, respectively, where an articulatable delivery catheter maybe steered within the imaging hood or a distal portion of the deployment catheter itself may be steered.
- FIGS. 4A to 4C show side and cross-sectional end views, respectively, of another variation having an off-axis imaging capability.
- FIGS. 4D and 4E show examples of various visualization imagers which may be utilized within or along the imaging hood.
- FIG. 5 shows an illustrative view of an example of a tissue imager advanced intravascularly within a heart for imaging tissue regions within an atrial chamber.
- FIGS. 6A to 6C illustrate deployment catheters having one or more optional inflatable balloons or anchors for stabilizing the device during a procedure.
- FIGS. 7A and 7B illustrate a variation of an anchoring mechanism such as a helical tissue piercing device for temporarily stabilizing the imaging hood relative to a tissue surface.
- an anchoring mechanism such as a helical tissue piercing device for temporarily stabilizing the imaging hood relative to a tissue surface.
- FIG. 7C shows another variation for anchoring the imaging hood having one or more tubular support members integrated with the imaging hood; each support members may define a lumen therethrough for advancing a helical tissue anchor within.
- FIG. 8A shows an illustrative example of one variation of how a tissue imager may be utilized with an imaging device.
- FIG. 8B shows a further illustration of a hand-held variation of the fluid delivery and tissue manipulation system.
- FIGS. 9A to 9C illustrate an example of capturing several images of the tissue at multiple regions.
- FIGS. 10A and 10B show charts illustrating how fluid pressure within the imaging hood may be coordinated with the surrounding blood pressure; the fluid pressure in the imaging hood may be coordinated with the blood pressure or it may be regulated based upon pressure feedback from the blood.
- FIGS. 11A and 11B show side and end views, respectively, of a hood and catheter engaging and visualizing the pulmonary vein ostium while temporarily tethered via a deployable anchor positioned within the pulmonary vein such that blood flow through the pulmonary vein is unobstructed.
- FIGS. 12A and 12B show side and end views, respectively, of the hood and catheter articulated around the pulmonary vein ostium while ablating and/or visualizing the underlying tissue.
- FIGS. 13A to 13C show end views of the device with the pulmonary vein anchor acting as a guide to ensure hood stability while the hood is articulated circumferentially along the pulmonary vein ostium while leaving the blood flow through the ostium unimpeded.
- FIGS. 14A and 14B show partial cross-sectional side views of a helical anchor constrained in its low-profile configuration within a cylindrical sheath and deployed in its expanded and unconstrained configuration.
- FIG. 14C shows a partial cross-sectional side view of the helical anchor temporarily secured within the pulmonary vein while allowing for blood flow through the vessel to continue unimpeded or unobstructed.
- FIGS. 15A and 15B show partial cross-sectional side views of a basket anchor constrained in its low-profile configuration within a cylindrical sheath and deployed in its expanded and unconstrained configuration.
- FIG. 15C shows a partial cross-sectional side view of the basket anchor temporarily secured within the pulmonary vein while allowing for blood flow through the vessel to continue unimpeded or unobstructed.
- FIGS. 16A and 16B show partial cross-sectional side views of a mesh anchor constrained in its low-profile configuration within a cylindrical sheath and deployed in its expanded and unconstrained configuration.
- FIG. 16C shows a partial cross-sectional side view of the mesh anchor temporarily secured within the pulmonary vein while allowing for blood flow through the vessel to continue unimpeded or unobstructed.
- FIGS. 17A and 17B show side views of an inflatable balloon anchor assembly in its low profile configuration and its inflated configuration, respectively, where the assembly is expandable into a staggered configuration such that blood may still flow unobstructed past the inflated balloons.
- FIGS. 18A and 18B show a variation of the tissue visualization catheter having a reconfigurable flap which is configured to pivot about the contact lip or edge of the hood from its low profile configuration to its extended configuration, respectively.
- FIGS. 19A and 19B show perspective views of the device of FIGS. 18A and 18 B with the flap shown in its low profile and extended configurations, respectively.
- FIG. 20 shows a side view of the hood having the flap deployed and engaged along the PV ostium to act as a guide for articulating the hood circumferentially.
- FIGS. 21A to 21C show end views of the catheter and hood having the deployed flap engaged along the pulmonary vein ostium such that the blood flow through the vessel is unimpeded while circumferentially ablating the underlying tissue under direct visualization.
- FIG. 22 shows a perspective view of another variation having an anchor extending from a side port for deployment within the vessel lumen.
- FIGS. 23A and 23B show perspective and end views, respectively, of the anchor engaged within a first pulmonary vein while the tissue around adjacent ostia are ablated in an encircling lesion to electrically isolate the vessels.
- a tissue-imaging and manipulation apparatus described below is able to provide real-time images in vivo of tissue regions within a body lumen such as a heart, which is filled with blood flowing dynamically therethrough and is also able to provide intravascular tools and instruments for performing various procedures upon the imaged tissue regions.
- Such an apparatus may be utilized for many procedures, e.g., facilitating transseptal access to the left atrium, cannulating the coronary sinus, diagnosis of valve regurgitation/stenosis, valvuloplasty, atrial appendage closure, arrhythmogenic focus ablation, among other procedures.
- Further examples of tissue visualization catheters which may be utilized are shown and described in further detail in U.S. patent application Ser. No. 11/259,498 filed Oct. 25, 2005, which has been incorporated hereinabove by reference in its entirety.
- tissue imaging and manipulation assembly 10 may be delivered intravascularly through the patient's body in a low-profile configuration via a delivery catheter or sheath 14 .
- tissue such as the mitral valve located at the outflow tract of the left atrium of the heart
- it is generally desirable to enter or access the left atrium while minimizing trauma to the patient.
- one conventional approach involves puncturing the intra-atrial septum from the right atrial chamber to the left atrial chamber in a procedure commonly called a transseptal procedure or septostomy.
- transseptal access to the left atrial chamber of the heart may allow for larger devices to be introduced into the venous system than can generally be introduced percutaneously into the arterial system.
- imaging hood 12 When the imaging and manipulation assembly 10 is ready to be utilized for imaging tissue, imaging hood 12 may be advanced relative to catheter 14 and deployed from a distal opening of catheter 14 , as shown by the arrow. Upon deployment, imaging hood 12 may be unconstrained to expand or open into a deployed imaging configuration, as shown in FIG. 1B .
- Imaging hood 12 may be fabricated from a variety of pliable or conformable biocompatible material including but not limited to, e.g., polymeric, plastic, or woven materials.
- a woven material is Kevlar® (E. I.
- imaging hood 12 may be fabricated from a translucent or opaque material and in a variety of different colors to optimize or attenuate any reflected lighting from surrounding fluids or structures, i.e., anatomical or mechanical structures or instruments. In either case, imaging hood 12 may be fabricated into a uniform structure or a scaffold-supported structure, in which case a scaffold made of a shape memory alloy, such as Nitinol, or a spring steel, or plastic, etc., may be fabricated and covered with the polymeric, plastic, or woven, material.
- a shape memory alloy such as Nitinol, or a spring steel, or plastic, etc.
- imaging hood 12 may comprise any of a wide variety of barriers or membrane structures, as may generally be used to localize displacement of blood or the like from a selected volume of a body lumen or heart chamber.
- a volume within an inner surface 13 of imaging hood 12 will be significantly less than a volume of the hood 12 between inner surface 13 and outer surface 11 .
- Imaging hood 12 may be attached at interface 24 to a deployment catheter 16 which may be translated independently of deployment catheter or sheath 14 . Attachment of interface 24 may be accomplished through any number of conventional methods.
- Deployment catheter 16 may define a fluid delivery lumen 18 as well as an imaging lumen 20 within which an optical imaging fiber or assembly may be disposed for imaging tissue.
- imaging hood 12 When deployed, imaging hood 12 may expand into any number of shapes, e.g., cylindrical, conical as shown, semi-spherical, etc., provided that an open area or field 26 is defined by imaging hood 12 . The open area 26 is the area within which the tissue region of interest may be imaged.
- Imaging hood 12 may also define an atraumatic contact lip or edge 22 for placement or abutment against the tissue region of interest.
- the diameter of imaging hood 12 at its maximum fully deployed diameter is typically greater relative to a diameter of the deployment catheter 16 (although a diameter of contact lip or edge 22 may be made to have a smaller or equal diameter of deployment catheter 16 ).
- the contact edge diameter may range anywhere from 1 to 5 times (or even greater, as practicable) a diameter of deployment catheter 16 .
- FIG. 1C shows an end view of the imaging hood 12 in its deployed configuration. Also shown are the contact lip or edge 22 and fluid delivery lumen 18 and imaging lumen 20 .
- the imaging and manipulation assembly 10 may additionally define a guidewire lumen therethrough, e.g., a concentric or eccentric lumen, as shown in the side and end views, respectively, of FIGS. 1D to 1F .
- the deployment catheter 16 may define guidewire lumen 19 for facilitating the passage of the system over or along a guidewire 17 , which may be advanced intravascularly within a body lumen. The deployment catheter 16 may then be advanced over the guidewire 17 , as generally known in the art.
- the displacing fluid may be pumped at positive pressure through fluid delivery lumen 18 until the fluid fills open area 26 completely and displaces any fluid 28 from within open area 26 .
- the displacing fluid flow may be laminarized to improve its clearing effect and to help prevent blood from re-entering the imaging hood 12 .
- fluid flow may be started before the deployment takes place.
- the displacing fluid, also described herein as imaging fluid may comprise any biocompatible fluid, e.g., saline, water, plasma, etc., which is sufficiently transparent to allow for relatively undistorted visualization through the fluid.
- any number of therapeutic drugs may be suspended within the fluid or may comprise the fluid itself which is pumped into open area 26 and which is subsequently passed into and through the heart and the patient body.
- deployment catheter 16 may be manipulated to position deployed imaging hood 12 against or near the underlying tissue region of interest to be imaged, in this example a portion of annulus A of mitral valve MV within the left atrial chamber.
- the translucent fluid 28 such as saline, may then be pumped through fluid delivery lumen 18 , intermittently or continuously, until the blood 30 is at least partially, and preferably completely, displaced from within open area 26 by fluid 28 , as shown in FIG. 2B .
- edge 22 need not directly contact the underlying tissue, it is at least preferably brought into close proximity to the tissue such that the flow of clear fluid 28 from open area 26 may be maintained to inhibit significant backflow of blood 30 bade into open area 26 .
- Contact edge 22 may also be made of a soft elastomeric material such as certain soft grades of silicone or polyurethane, as typically known, to help contact edge 22 conform to an uneven or rough underlying anatomical tissue surface.
- the fluid 28 may be pumped, temporarily or sporadically only until a clear view of the tissue is available to be imaged and recorded, at which point the fluid flow 28 may cease and blood 30 may be allowed to seep or flow back into imaging hood 12 . This process may be repeated a number of times at the same tissue region or at multiple tissue regions.
- a number of articulation and manipulation controls may be utilized.
- one or more push-pull wires 42 may be routed through deployment catheter 16 for steering the distal end portion of the device in various directions 46 to desirably position the imaging hood 12 adjacent to a region of tissue to be visualized.
- deployment catheter 16 and imaging hood 12 may be articulated into any number of configurations 44 .
- the push-pull wire or wires 42 may be articulated via their proximal ends from outside the patient body manually utilizing one or more controls.
- deployment catheter 16 may be articulated by computer control, as further described below.
- an articulatable delivery catheter 48 which may be articulated via one or more push-pull wires and having an imaging lumen and one or more working lumens, may be delivered through the deployment catheter 16 and into imaging hood 12 .
- the clear displacing fluid may be pumped through delivery catheter 48 or deployment catheter 16 to clear the field within imaging hood 12 .
- the articulatable delivery catheter 48 may be articulated within the imaging hood to obtain a better image of tissue adjacent to the imaging hood 12 .
- articulatable delivery catheter 48 may be articulated to direct an instrument or tool passed through the catheter 48 , as described in detail below, to specific areas of tissue imaged through imaging hood 12 without having to reposition deployment catheter 16 and re-clear the imaging field within hood 12 .
- a distal portion of the deployment catheter 16 itself may comprise a distal end 49 which is articulatable within imaging hood 12 , as shown in FIG. 3C .
- Directed imaging, instrument delivery, etc. may be accomplished directly through one or more lumens within deployment catheter 16 to specific regions of the underlying tissue imaged within imaging hood 12 .
- Visualization within the imaging hood 12 may be accomplished through an imaging lumen 20 defined through deployment catheter 16 , as described above. In such a configuration, visualization is available in a straight-line manner, i.e., images are generated from the field distally along a longitudinal axis defined by the deployment catheter 16 .
- an articulatable imaging assembly having a pivotable support member 50 may be connected to, mounted to, or otherwise passed through deployment catheter 16 to provide for visualization off-axis relative to the longitudinal axis defined by deployment catheter 16 , as shown in FIG. 4A .
- Support member 50 may have an imaging element 52 , e.g., a CCD or CMOS imager or optical fiber, attached at its distal end with its proximal end connected to deployment catheter 16 via a pivoting connection 54 .
- the optical fibers 58 may be passed through deployment catheter 16 , as shown in the cross-section of FIG. 4B , and routed through the support member 50 .
- the use of optical fibers 58 may provide for increased diameter sizes of the one or several lumens 56 through deployment catheter 16 for the passage of diagnostic and/or therapeutic tools therethrough.
- electronic chips such as a charge coupled device (CCD) or a CMOS imager, which are typically known, may be utilized in place of the optical fibers 58 , in which case the electronic imager may be positioned in the distal portion of the deployment catheter 16 with electric wires being routed proximally through the deployment catheter 16 .
- CCD charge coupled device
- CMOS imager which are typically known
- the electronic imagers may be wirelessly coupled to a receiver for the wireless transmission of images.
- Additional optical fibers or light emitting diodes (LEDs) can be used to provide lighting for the image or operative theater, as described below in further detail.
- Support member 50 may be pivoted via connection 54 such that the member 50 can be positioned in a low-profile configuration within channel or groove 60 defined in a distal portion of catheter 16 , as shown in the cross-section of FIG. 4C .
- support member 50 can be positioned within channel or groove 60 with imaging hood 12 also in its low-profile configuration.
- imaging hood 12 may be expanded into its deployed configuration and support member 50 may be deployed into its off-axis configuration for imaging the tissue adjacent to hood 12 , as in FIG. 4A .
- Other configurations for support member 50 for off-axis visualization may be utilized, as desired.
- FIG. 4D shows a partial cross-sectional view of an example where one or more optical fiber bundles 62 may be positioned within the catheter and within imaging hood 12 to provide direct in-line imaging of the open area within hood 12 .
- FIG. 4E shows another example where an imaging element 64 (e.g., CCD or CMOS electronic imager) may be placed along an interior surface of imaging hood 12 to provide imaging of the open area such that the imaging element 64 is off-axis relative to a longitudinal axis of the hood 12 .
- the off-axis position of element 64 may provide for direct visualization and uninhibited access by instruments from the catheter to the underlying tissue during treatment.
- FIG. 5 shows an illustrative cross-sectional view of a heart H having tissue regions of interest being viewed via an imaging assembly 10 .
- delivery catheter assembly 70 may be introduced percutaneously into the patient's vasculature and advanced through the superior vena cava SVC and into the right atrium RA.
- the delivery catheter or sheath 72 may be articulated through the atrial septum AS and into the left atrium LA for viewing or treating the tissue, e.g., the annulus A, surrounding the mitral valve MV.
- deployment catheter 16 and imaging hood 12 may be advanced out of delivery catheter 72 and brought into contact or in proximity to the tissue region of interest.
- delivery catheter assembly 70 may be advanced through the inferior vena cava IVC, if so desired.
- other regions of the heart H e.g., the right ventricle RV or left ventricle LV, may also be accessed and imaged or treated by imaging assembly 10 .
- the delivery catheter or sheath 14 may comprise a conventional intra-vascular catheter or an endoluminal delivery device.
- robotically-controlled delivery catheters may also be optionally utilized with the imaging assembly described herein, in which case a computer-controller 74 may be used to control the articulation and positioning of the delivery catheter 14 .
- An example of a robotically-controlled delivery catheter which may be utilized is described in further detail in US Pat. Pub. 2002/0087169 A1 to Brock et al. entitled “Flexible Instrument”, which is incorporated herein by reference in its entirety.
- Other robotically-controlled delivery catheters manufactured by Hansen Medical, Inc. may also be utilized with the delivery catheter 14 .
- one or more inflatable balloons or anchors 76 may be positioned along the length of catheter 16 , as shown in FIG. 6A .
- the inflatable balloons 76 may be inflated from a low-profile into their expanded configuration to temporarily anchor or stabilize the catheter 16 position relative to the heart H.
- FIG. 6B shows a first balloon 78 inflated while FIG. 6C also shows a second balloon 80 inflated proximal to the first balloon 78 .
- the septal wall AS may be wedged or sandwiched between the balloons 78 , 80 to temporarily stabilize the catheter 16 and imaging hood 12 .
- a single balloon 78 or both balloons 78 , 80 may be used. Other alternatives may utilize expandable mesh members, malecots, or any other temporary expandable structure.
- the balloon assembly 76 may be deflated or re-configured into a low-profile for removal of the deployment catheter 16 .
- various anchoring mechanisms may be optionally employed for temporarily holding the imaging hood 12 against the tissue.
- Such anchoring mechanisms may be particularly useful for imaging tissue which is subject to movement, e.g., when imaging tissue within the chambers of a beating heart.
- a tool delivery catheter 82 having at least one instrument lumen and an optional visualization lumen may be delivered through deployment catheter 16 and into an expanded imaging hood 12 .
- anchoring mechanisms such as a helical tissue piercing device 84 may be passed through the tool delivery catheter 82 , as shown in FIG. 7A , and into imaging hood 12 .
- the helical tissue engaging device 84 may be torqued from its proximal end outside the patient body to temporarily anchor itself into the underlying tissue surface T. Once embedded within the tissue T, the helical tissue engaging device 84 may be pulled proximally relative to deployment catheter 16 while the deployment catheter 16 and imaging hood 12 are pushed distally, as indicated by the arrows in FIG. 7B , to gently force the contact edge or lip 22 of imaging hood against the tissue T. The positioning of the tissue engaging device 84 may be locked temporarily relative to the deployment catheter 16 to ensure secure positioning of the imaging hood 12 during a diagnostic or therapeutic procedure within the imaging hood 12 .
- tissue engaging device 84 may be disengaged from the tissue by torquing its proximal end in the opposite direction to remove the anchor form the tissue T and the deployment catheter 16 may be repositioned to another region of tissue where the anchoring process may be repeated or removed from the patient body.
- the tissue engaging device 84 may also be constructed from other known tissue engaging devices such as vacuum-assisted engagement or grasper-assisted engagement tools, among others.
- helical anchor 84 is shown, this is intended to be illustrative and other types of temporary anchors may be utilized, e.g., hooked or barbed anchors, graspers, etc.
- the tool delivery catheter 82 may be omitted entirely and the anchoring device may be delivered directly through a lumen defined through the deployment catheter 16 .
- FIG. 7C shows an imaging hood 12 having one or more tubular support members 86 , e.g., four support members 86 as shown, integrated with the imaging hood 12 .
- the tubular support members 86 may define lumens therethrough each having helical tissue engaging devices 88 positioned within.
- the helical tissue engaging devices 88 may be urged distally to extend from imaging hood 12 and each may be torqued from its proximal end to engage the underlying tissue T.
- Each of the helical tissue engaging devices 88 may be advanced through the length of deployment catheter 16 or they may be positioned within tubular support members 86 during the delivery and deployment of imaging hood 12 . Once the procedure within imaging hood 12 is finished, each of the tissue engaging devices 88 may be disengaged from the tissue and the imaging hood 12 may be repositioned to another region of tissue or removed from the patient body.
- FIG. 8A An illustrative example is shown in FIG. 8A of a tissue imaging assembly connected to a fluid delivery system 90 and to an optional processor 98 and image recorder and/or viewer 100 .
- the fluid delivery system 90 may generally comprise a pump 92 and an optional valve 94 for controlling the flow rate of the fluid into the system.
- a fluid reservoir 96 fluidly connected to pump 92 , may hold the fluid to be pumped through imaging hood 12 .
- An optional central processing unit or processor 98 may be in electrical communication with fluid delivery system 90 for controlling flow parameters such as the flow rate and/or velocity of the pumped fluid.
- the processor 98 may also be in electrical communication with an image recorder and/or viewer 100 for directly viewing the images of tissue received from within imaging hood 12 .
- Imager recorder and/or viewer 100 may also be used not only to record the image but also the location of the viewed tissue region, if so desired.
- processor 98 may also be utilized to coordinate the fluid flow and the image capture.
- processor 98 may be programmed to provide for fluid flow from reservoir 96 until the tissue area has been displaced of blood to obtain a clear image. Once the image has been determined to be sufficiently clear, either visually by a practitioner or by computer, an image of the tissue may be captured automatically by recorder 100 and pump 92 may be automatically stopped or slowed by processor 98 to cease the fluid flow into the patient.
- Other variations for fluid delivery and image capture are, of course, possible and the aforementioned configuration is intended only to be illustrative and not limiting.
- FIG. 8B shows a further illustration of a hand-held variation of the fluid delivery and tissue manipulation system 110 .
- system 110 may have a housing or handle assembly 112 which can be held or manipulated by the physician from outside the patient body.
- the fluid reservoir 114 shown in this variation as a syringe, can be fluidly coupled to the handle assembly 112 and actuated via a pumping mechanism 116 , e.g., lead screw.
- Fluid reservoir 114 may be a simple reservoir separated from the handle assembly 112 and fluidly coupled to handle assembly 112 via one or more tubes. The fluid flow rate and other mechanisms may be metered by the electronic controller 118 .
- Deployment of imaging hood 12 may be actuated by a hood deployment switch 120 located on the handle assembly 112 while dispensation of the fluid from reservoir 114 may be actuated by a fluid deployment switch 122 , which can be electrically coupled to the controller 118 .
- Controller 118 may also be electrically coupled to a wired or wireless antenna 124 optionally integrated with the handle assembly 112 , as shown in the figure.
- the wireless antenna 124 can be used to wirelessly transmit images captured from the imaging hood 12 to a receiver, e.g., via Bluetooth® wireless technology (Bluetooth SIG, Inc., Bellevue, Wash.), RF, etc., for viewing on a monitor 128 or for recording for later viewing.
- Articulation control of the deployment catheter 16 , or a delivery catheter or sheath 14 through which the deployment catheter 16 may be delivered may be accomplished by computer control as described above, in which case an additional controller may be utilized with handle assembly 112 .
- handle assembly 112 may incorporate one or more articulation controls 126 for manual manipulation of the position of deployment catheter 16 .
- Handle assembly 112 may also define one or more instrument ports 130 through which a number of intravascular tools may be passed for tissue manipulation and treatment within imaging hood 12 , as described further below.
- fluid or debris may be sucked into imaging hood 12 for evacuation from the patient body by optionally fluidly coupling a suction pump 132 to handle assembly 112 or directly to deployment catheter 16 .
- fluid may be pumped continuously into imaging hood 12 to provide for clear viewing of the underlying tissue.
- fluid may be pumped temporarily or sporadically only until a clear view of the tissue is available to be imaged and recorded, at which point the fluid flow may cease and the blood may be allowed to seep or flow back into imaging hood 12 .
- FIGS. 9A to 9C illustrate an example of capturing several images of the tissue at multiple regions.
- Deployment catheter 16 may be desirably positioned and imaging hood 12 deployed and brought into position against a region of tissue to be imaged, in this example the tissue surrounding a mitral valve MY within the left atrium of a patient's heart.
- the imaging hood 12 may be optionally anchored to the tissue, as described above, and then cleared by pumping the imaging fluid into the hood 12 . Once sufficiently clear, the tissue may be visualized and the image captured by control electronics 118 .
- the first captured image 140 may be stored and/or transmitted wirelessly 124 to a monitor 128 for viewing by the physician, as shown in FIG. 9A .
- the deployment catheter 16 may be then repositioned to an adjacent portion of mitral valve MV, as shown in FIG. 9B , where the process may be repeated to capture a second image 142 for viewing and/or recording.
- the deployment catheter 16 may again be repositioned to another region of tissue, as shown in FIG. 9C , where a third image 144 may be captured for viewing and/or recording. This procedure may be repeated as many times as necessary for capturing a comprehensive image of the tissue surrounding mitral valve MV, or any other tissue region.
- the pump may be stopped during positioning and blood or surrounding fluid may be allowed to enter within imaging hood 12 until the tissue is to be imaged, where the imaging hood 12 may be cleared, as above.
- the fluid when the imaging hood 12 is cleared by pumping the imaging fluid within for clearing the blood or other bodily fluid, the fluid may be pumped continuously to maintain the imaging fluid within the hood 12 at a positive pressure or it may be pumped under computer control for slowing or stopping the fluid flow into the hood 12 upon detection of various parameters or until a clear image of the underlying tissue is obtained.
- the control electronics 118 may also be programmed to coordinate the fluid flow into the imaging hood 12 with various physical parameters to maintain a clear image within imaging hood 12 .
- FIG. 10A shows a chart 150 illustrating how fluid pressure within the imaging hood 12 may be coordinated with the surrounding blood pressure.
- Chart 150 shows the cyclical blood pressure 156 alternating between diastolic pressure 152 and systolic pressure 154 over time T due to the beating motion of the patient heart.
- the fluid pressure of the imaging fluid, indicated by plot 160 within imaging hood 12 may be automatically timed to correspond to the blood pressure changes 160 such that an increased pressure is maintained within imaging hood 12 which is consistently above the blood pressure 156 by a slight increase ⁇ P, as illustrated by the pressure difference at the peak systolic pressure 158 .
- This pressure difference, ⁇ P may be maintained within imaging hood 12 over the pressure variance of the surrounding blood pressure to maintain a positive imaging fluid pressure within imaging hood 12 to maintain a clear view of the underlying tissue.
- One benefit of maintaining a constant ⁇ P is a constant flow and maintenance of a clear field.
- FIG. 10B shows a chart 162 illustrating another variation for maintaining a clear view of the underlying tissue
- one or more sensors within the imaging hood 12 may be configured to sense pressure changes within the imaging hood 12 and to correspondingly increase the imaging fluid pressure within imaging hood 12 .
- This may result in a time delay, ⁇ T, as illustrated by the shifted fluid pressure 160 relative to the cycling blood pressure 156 , although the time delays ⁇ T may be negligible in maintaining the clear image of the underlying tissue.
- Predictive software algorithms can also be used to substantially eliminate this time delay by predicting when the next pressure wave peak will arrive and by increasing the pressure ahead of the pressure wave's arrival by an amount of time equal to the aforementioned time delay to essentially cancel the time delay out.
- imaging hood 12 The variations in fluid pressure within imaging hood 12 may be accomplished in part due to the nature of imaging hood 12 .
- An inflatable balloon which is conventionally utilized for imaging tissue, may be affected by the surrounding blood pressure changes.
- an imaging hood 12 retains a constant volume therewithin and is structurally unaffected by the surrounding blood pressure changes, thus allowing for pressure increases therewithin.
- the material that hood 12 is made from may also contribute to the manner in which the pressure is modulated within this hood 12 .
- a stiller hood material such as high durometer poly urethane or Nylon, may facilitate the maintaining of an open hood when deployed.
- a relatively lower durometer or softer material such as a low durometer PVC or polyurethane, may collapse from the surrounding fluid pressure and may not adequately maintain a deployed or expanded hood.
- the imaging hood itself may be formed into any number of configurations and the imaging assembly may also be utilized with any number of therapeutic tools, such as tissue ablation instruments, which may be deployed through the deployment catheter.
- tissue ablation instruments such as tissue ablation instruments
- One particular variation may employ an imaging hood having a tissue anchor deployable therethrough and into a portion of a body lumen such as the pulmonary vein. Once the anchor has been temporarily deployed and secured within the pulmonary vein, the hood and ablation instrument may be articulated around a circumference of the vein ostium or several ostia where the tissue may be ablated in a controlled and consistent manner to electrically isolate the tissue such that a conduction block is created.
- the imaging hood may be articulated such that blood flow through the pulmonary vein is unobstructed or uninhibited by the hood.
- the tissue surrounding the ostium may be visualized via the imaging hood prior to, during, or after the ablation to ensure that the appropriate tissue is suitably ablated for treating conditions such as atrial fibrillation.
- the distally located anchor which secures a relative position of the imaging hood with respect to the tissue may be maintained until the procedure is completed. After completion, the anchor may be at least partially withdrawn into the imaging hood or reconfigured into a low-profile shape to disengage the tissue and allow the imaging hood to be removed or repositioned in the patient body.
- FIGS. 11A and 11B show respective side and end views of visualization hood 12 placed against and visualizing a portion of the ostium, e.g., the ostium OS LS of the left superior pulmonary vein PV LS .
- Placement and movement of hood 12 about ostium OS LS may be facilitated by the deployment and placement of an anchor within the respective pulmonary vein while tethered to hood 12 or catheter 16 .
- the anchor situated within the pulmonary vein may be sufficiently open such that the anchor does not obstruct blood flow through the pulmonary vein.
- the pulmonary vein anchor may be configured as a helical anchor 170 which is attached to an anchor member 172 , e.g., a guidewire, such that helical anchor 170 may be advanced through delivery catheter 16 in a low-profile configuration and then slowly expanded when advanced distally out of catheter 16 .
- anchor member 170 may be advanced distally within the pulmonary vein until anchor 170 is expanded into contact against the wall of the pulmonary vein, as shown in FIG. 11A .
- a deployment sheath may be advanced through a working channel of deployment catheter 16 , through hood 12 , and distally into the pulmonary vein.
- helical anchor 170 may be advanced distally and/or the sheath may be retracted proximally to deploy and expand the anchor 170 .
- Anchor 170 is described in further detail below.
- hood 12 may be placed into contact against a portion of ostium OS LS by pushing hood 12 along anchor member 172 distally in the direction towards anchor 170 until hood 12 is pressed against the tissue surface. Once pressed against the tissue surface, the transparent purging fluid 28 may be pumped into open area or field 26 to enable direct visualization of the tissue surrounding ostium OS LS while surrounded by blood 30 .
- unobstructed blood flow 178 may continue through the pulmonary vein PV LS past anchor 170 because of its non-obstructive configuration while the tissue underlying hood 12 is visualized by imaging element 176 , e.g., CCD, CMOS, or optical fiber, etc., positioned upon or along hood 12 or within catheter 16 .
- imaging element 176 e.g., CCD, CMOS, or optical fiber, etc.
- anchor 170 is able to be secured, against the vessel wall without blocking the vessel lumen.
- Unobstructed blood flow is further facilitated by positioning the hood 12 laterally relative to the ostium OS LS such that the vessel opening remains minimally obstructed or completely unobstructed, as shown in FIG. 11B .
- an instrument such as ablation probe 174 may be advanced within hood 12 and placed into contact against or in proximity to the underlying tissue which may be ablated while under direct visualization via imaging element 176 .
- Ablation probe 174 may ablate the tissue immediately underlying hood 12 and hood 12 may then be repositioned over an adjacent region of tissue to be ablated where the process may be repeated.
- hood 12 may be moved circumferentially about ostium OS LS while ablating the underlying tissue in a continuous manner.
- anchor member 172 may act as a guide to ensure that hood 12 stays or tracks circumferentially around ostium OS LS during ablation. As shown in the side and end views of FIGS.
- hood 12A and 12B respectively, an example of how hood 12 may be moved around the ostium OS LS during ablation is illustrated where hood 12 is moved in a counter-clockwise motion relative to ostium OS LS .
- hood 12 may be moved in a clockwise motion as well.
- hood 12 may continue to capture a portion of the ostium OS LS as anchor 170 and anchor member 172 may confine the motion of the hood 12 to the circumference of the ostium OS LS .
- a number of discrete lesions 182 may be formed upon the tissue underlying hood 12 . Repositioning of hood 12 adjacent to the ablated tissue may allow for the creation of another discrete lesion 182 which may be overlapped upon one another such that a single continuous lesion 180 is collectively formed. This process may be repeated until the desired circumference of tissue is ablated.
- the continuous lesion 180 may be formed while simultaneously ablating and moving hood 12 and ablation probe 174 around ostium OS LS such that a single continuous line of tissue is ablated. In either case, the underlying tissue being ablated may be viewed under direct visualization from imaging element 176 .
- FIGS. 13A to 13C illustrate hood 12 and ablation probe 174 being constrained by anchor member 172 coupled to anchor 170 to follow a circumferential path around the ostium OS LS as hood 12 is articulated via catheter 16 .
- hood 12 may be articulated to follow a clockwise direction as well.
- FIGS. 13A and 13B illustrate ablation probe 174 being used to create a series of overlapping discrete lesions 182 to create a continuous lesion 180 such that the entire circumference of tissue surrounding ostium OS LS is ablated to completely electrically isolate the ostium OS LS .
- FIG. 13A and 13B illustrate ablation probe 174 being used to create a series of overlapping discrete lesions 182 to create a continuous lesion 180 such that the entire circumference of tissue surrounding ostium OS LS is ablated to completely electrically isolate the ostium OS LS .
- FIG. 13C illustrates the resulting lesion 180 formed by the ablated tissue once anchor 170 and anchor member 172 have been withdrawn and hood 12 has been removed from the ostium OS LS .
- lesion 180 is illustrated as encircling the entire circumference of ostium OS LS one or more discrete portions of the surrounding tissue may be ablated instead depending upon the desired results.
- the circumference, or portions, of the circumference, of ostium OS LS may be ablated while under direct visualization within hood 12 while allowing for obstructed blood flow 178 from the respective pulmonary vein.
- helical anchor 170 may be advanced through catheter 16 .and through hood 12 in a low-profile configuration while constrained either by a delivery lumen of catheter 16 or by an optional anchor sheath 190 advanced through the delivery lumen while constraining anchor 170 .
- FIG. 14A shows an example of an optional anchor sheath 190 having helical anchor 170 extending from anchor member 172 constrained within anchor lumen 192 in its low-profile configuration.
- anchor 170 When helical anchor 170 is to be deployed from anchor lumen 192 , anchor 170 may be advanced relative to sheath 190 and/or sheath 190 may be retracted relative to anchor 170 such that helical anchor 170 may be extended beyond lumen 192 such that anchor 170 is unconstrained and allowed to expand radially, as illustrated in FIG. 14B .
- helical anchor 170 may be expanded or reconfigured such that anchor 176 does not obstruct blood flow 178 within the pulmonary vein PV LS .
- the expanded anchor 170 may provide engagement and orientation for hood 12 relative to the underlying tissue surrounding the ostium to conduct direct visualization and ablation of the tissue surrounding the ostium OS LS , as described above.
- the anchor 170 may secure itself to the vessel wall by expanding laterally, e.g., perpendicularly relative to a longitudinal axis of the anchor 170 , and applying a radial outward force upon the tissue walls of the vessel.
- the helical anchor 170 can be formed from a wire made from a variety of materials, e.g., shape memory alloys such as Nitinol. When the helical anchor 170 is retracted back into sheath 190 , the anchor 170 may return to its original low-profile shape for repositioning or for removal from the patient.
- FIGS. 15A and 15B show partial cross-sectional views of another variation of the anchor for placement within the pulmonary vein where the anchor is configured as a reconfigurable basket anchor 200 which is deliverable in its low-profile configuration where basket anchor 200 is constrained within lumen 192 of sheath 190 , as shown in FIG. 15A , and deployable into an expanded or extended basket configuration, as shown in FIG. 15B .
- Basket anchor 200 may be formed to have several reconfigurable basket arms or members 206 which are each connected at a distal connection 202 and at a proximal connection 204 . Basket anchor 200 may extend distally from anchor member 208 such that distal movement of anchor member 208 (and/or proximal retraction of sheath 190 ) may urge basket anchor 200 out of lumen 192 where basket arms or members 206 may expand laterally into its basket configuration, e.g., where arms or members 206 reconfigure perpendicularly relative to the axis of the basket 200 , and into contact against the vessel walls, as shown in FIG. 15C . Fractional contact between arms or members 206 and the tissue surface in contact provides additional force to secure the anchor 200 in place. Even in its expanded configuration, basket anchor 200 may provide an open pathway for blood flow 178 to continue relatively unobstructed between the arms or members 206 and through the vessel.
- basket anchor 200 can be fabricated from shape memory alloy tubing such as Nitinol or from metal wires or ribbons such as stainless steel, titanium, etc. When retracted proximally back into sheath 190 , the basket anchor 200 may return to its original low-profile shape for repositioning within the same or different vessel or for removal from the patient.
- shape memory alloy tubing such as Nitinol
- metal wires or ribbons such as stainless steel, titanium, etc.
- FIGS. 16A and 16B show partial cross-sectional side views of an anchor configured as a mesh anchor 210 .
- This mesh anchor 210 variation may anchor itself to the walls of the pulmonary vein PV LS by expanding laterally into a basket-like frame, e.g., perpendicularly relative to the longitudinal axis of the anchor 210 , and applying a radial outward force on the wails of the vessel.
- the anchor 210 may generally comprise multiple wire or ribbon members 216 which are woven, interwoven, or interlaced with respect to one another to form the mesh which is connected at a distal connection 212 and a proximal connection 214 and attached, coupled, or otherwise extending from anchor member 218 .
- the wire or ribbon members 216 can be formed from shape memory alloy such as Nitinol or from a polymeric of plastic material such as PET.
- shape memory alloy such as Nitinol
- PET polymeric of plastic material
- the pulmonary vein anchor may be configured as a balloon anchor assembly 220 having several balloon members which are inflatable into a staggered pattern for securement within the vessel.
- the staggered balloon assembly 220 may be advanced at least partially within, e.g., the pulmonary vein PV LS , while in a deflated or low-profile configuration.
- staggered balloon anchor assembly 220 may be infused with a gas (such as nitrogen) or fluid (such as saline) via inflation lumen 228 to expand several balloons positioned in a staggered pattern along the inflation lumen 228 .
- first offset balloon 222 may be positioned distally along lumen 228 while second offset balloon 224 may be positioned proximally and in an offset position relative to first offset balloon 222 .
- a third offset balloon 226 may be positioned proximally of second balloon 224 such that it is offset with respect to second balloon 224 and/or first balloon 222 , as illustrated in FIG. 17B .
- three balloon members are shown in this example, other variations may utilize two balloons or more than three balloons.
- balloon members may be configured into other shapes which still allow for blood flow through the vessel, e.g., one or more toroidal shaped balloon members.
- blood flow 178 may continue through the pulmonary vein PV LS such that the blood is able to meander in an offset flow pattern 230 past the staggered balloons.
- the staggered balloons can be made from a variety of materials typically utilized for biocompatible inflatable balloons, e.g., medical grade elastomers such as C-flex, chronoprene, silicone or polyurethane, etc.
- FIGS. 18A and 18B show a variation of the tissue visualization catheter having a reconfigurable flap 240 which is configured to pivot about the contact lip or edge 22 of the hood 12 .
- flap 240 may remain folded inwardly along the inner wall of the hood 12 .
- An inflation lumen 246 may extend from the catheter 16 along or within the wall of the hood 12 and terminate proximal to the flap 240 at an inflatable member or balloon 242 positioned between flap 240 and hood 12 .
- Balloon 242 may be fabricated from a variety of materials, such as C-flex, chronoprene, polyurethane, etc.
- FIGS. 19A and 19B illustrate perspective views of flap 240 in its low-profile configuration and its extended configuration, respectively, corresponding to FIGS. 18A and 18B above.
- flap 240 in its extended position may act as a guide for the hood 12 to trace the ostium OS LS to ensure that hood 12 moves along the circumference of the ostium OS LS .
- hood 12 may be positioned in proximity to the vessel and ostium to be treated.
- flap 240 may be extended and hood 12 may be placed laterally relative to the vessel such that flap 240 is positioned at least partially along the opening of the pulmonary vein PV LS and only a small portion of the vessel opening is covered such that blood flow 178 through the vessel may continue unobstructed by the hood 12 .
- hood 12 is desirably positioned upon the ostium OS LS to allow the hood 12 and ablation probe 174 positioned therewithin to treat the underlying tissue while under direct visualization through the hood 12 .
- hood 12 may be moved circumferentially via catheter 16 , or at least partially, around the ostium OS LS to create one or more discrete lesions 182 or a continuous lesion 180 .
- FIG. 21C illustrates the resulting lesion 180 created circumferentially about the ostium OS LS to electrically isolate the tissue region.
- FIG. 22 shows a perspective view of an example of a device utilizing a side port 250 defined along the catheter 16 proximal to the hood 12 for intravascularly creating lesions around multiple ostia.
- the anchor configuration is illustrated with helical anchor 170 attached to anchor member 172 extending through port 250 , other anchors which are non-obstructing to the blood flow through the vessel may be utilized, such as basket anchors, mesh anchors, staggered, balloons, etc.
- An anchor deployed from the side port 250 of the catheter 16 may provide hood 12 additional degrees-of-freedom of controlled motion within the chamber (such as the left atrium LA) of the heart.
- anchor 170 may be deployed through port 250 proximal to the hood 12 and advanced into, e.g., pulmonary vein PV LS , by advancing anchor member 172 (indicated by the direction of advancement 252 ) where it may be secured within the vessel without obstructing blood flow therethrough, as shown in the perspective view of FIG. 23A .
- Hood 12 may then be articulated via catheter 16 (indicated by the direction of articulation 254 ) while tethered and guided by anchor member 172 to facilitate the ablation process by allowing hood 12 to be maneuvered especially when isolating two or more ostia, e.g., left superior ostium OS LS and left inferior ostium OS LS , within one continuous circumferential lesion, as shown in FIG. 23B .
- Other tissue regions may be ablated in the same manner to create lesion patterns around the various ostia or around all four ostia within the left atrium LA.
- the side ported anchor may also provide additional apposition strength for the hood 12 to engage the ablated tissue surface when the anchor 170 is pulled from the side port 250 .
- Another variation may include having two or more side ports near or at the distal end of the catheter 16 proximal to hood 12 , with each side port deploying a respective anchor.
- each side port deploying a respective anchor.
- one anchor secures itself to the right superior/inferior pulmonary vein while the other pulmonary vein anchor secures itself within the left superior/inferior PV
- navigation around all four pulmonary vein ostia and apposition to target tissue surface in the vicinity of the four pulmonary vein ostia can be achieved. This can be made so by pulling on each of the two anchor members with varying tension and by rotating the hood 12 about the axis of the anchor members.
- Both linear lesions connecting the pulmonary veins and circumferential lesions around the respective ostia can be formed by maneuvering the hood 12 accordingly.
Abstract
Description
- This application claims the benefit of priority to U.S. Prov.
Patent Application 60/870,598 filed Dec. 18, 2006, which is incorporated herein by reference in its entirety. - The present invention relates generally to medical devices used for accessing, visualizing, and/or treating regions of tissue within a body. More particularly, the present invention relates to methods and apparatus for intravascularly accessing, visualizing, and/or treating tissue regions at or around the ostia of the pulmonary veins of the heart, without obstructing blood flow from the pulmonary vein.
- Conventional devices for accessing and visualizing interior regions of a body lumen are known. For example, ultrasound devices have been used to produce images from within a body in vivo. Ultrasound has been used both with and without contrast agents, which typically enhance ultrasound-derived images.
- Other conventional methods have utilized catheters or probes having position sensors deployed within the body lumen, such as the interior of a cardiac chamber. These types of positional sensors are typically used to determine the movement of a cardiac tissue surface or the electrical activity within the cardiac tissue. When a sufficient number of points have been sampled by the sensors, a “map” of the cardiac tissue may be generated.
- Another conventional device utilizes an inflatable balloon which is typically introduced intravascularly in a deflated state and then inflated against the tissue region to be examined. Imaging is typically accomplished by an optical fiber or other apparatus such as electronic chips for viewing the tissue through the membrane(s) of the inflated balloon. Moreover, the balloon must generally be inflated for imaging. Other conventional balloons utilize a cavity or depression formed at a distal end of the inflated balloon. This cavity or depression is pressed against the tissue to be examined and is flushed with a clear fluid to provide a clear pathway through the blood.
- However, such imaging balloons have many inherent disadvantages. For instance, such balloons generally require that the balloon be inflated to a relatively large size which may undesirably displace surrounding tissue and interfere with fine positioning of the imaging system against the tissue. Moreover, the working area created by such inflatable balloons are generally cramped and limited in size. Furthermore, inflated balloons may be susceptible to pressure changes in the surrounding fluid. For example, if the environment surrounding the inflated balloon undergoes pressure changes, e.g., during systolic and diastolic pressure cycles in a beating heart, the constant pressure change may affect the inflated balloon volume and its positioning to produce unsteady or undesirable conditions for optimal tissue imaging.
- Accordingly, these types of imaging modalities are generally unable to provide desirable images useful for sufficient diagnosis and therapy of the endoluminal structure, due in part to factors such as dynamic forces generated by the natural movement of the heart. Moreover, anatomic structures within the body can occlude or obstruct the image acquisition process. Also, the presence and movement of opaque bodily fluids such as blood generally make in vivo imaging of tissue regions within the heart difficult.
- Other external imaging modalities are also conventionally utilized. For example, computed tomography (CT) and magnetic resonance imaging (MRI) are typical modalities which are widely used to obtain images of body lumens such as the interior chambers of the heart. However, such imaging modalities fail to provide real-time imaging for intra-operative therapeutic procedures. Fluoroscopic imaging, for instance, is widely used to identify anatomic landmarks within the heart and other regions of the body. However, fluoroscopy fails to provide an accurate image of the tissue quality or surface and also fails to provide for instrumentation for performing tissue manipulation or other therapeutic procedures upon the visualized tissue regions. In addition, fluoroscopy provides a shadow of the intervening tissue onto a plate or sensor when it may be desirable to view the intraluminal surface of the tissue to diagnose pathologies or to perform some form of therapy on it.
- Moreover, many of the conventional imaging systems lack the capability to provide therapeutic treatments or are difficult to manipulate in providing effective therapies. For instance, the treatment in a patient's heart for atrial fibrillation is generally made difficult by a number of factors, such as visualization of the target tissue, access to the target tissue, and instrument articulation and management, amongst others.
- Conventional catheter techniques and devices, for example such as those described in U.S. Pat. Nos. 5,895,417; 5,941,845; and 6,129,724, used on the epicardial surface of the heart may be difficult in assuring a transmural lesion or complete blockage of electrical signals. In addition, current devices may have difficulty dealing with varying thickness of tissue through which a transmural lesion desired.
- Conventional accompanying imaging devices, such as fluoroscopy, are unable to detect perpendicular electrode orientation, catheter movement during the cardiac cycle, and image catheter position throughout lesion formation. Without real-time visualization, it is difficult to reposition devices to another area that requires transmural lesion ablation. The absence of real-time visualization also poses the risk of incorrect placement and ablation of critical structures such as sinus node tissue which can lead to fatal consequences.
- Thus, a tissue imaging system which is able to provide real-time in vivo access to and images of tissue regions within body lumens such as the heart through opaque media such as blood and which also provides instruments for therapeutic procedures such as ablation of the ostia around the pulmonary veins are desirable.
- A tissue imaging and manipulation apparatus that may be utilized for procedures within a body lumen, such as the heart, in which visualization of the surrounding tissue is made difficult, if not impossible, by medium contained within the lumen such as blood, is described below. Generally, such a tissue imaging and manipulation apparatus comprises an optional delivery catheter or sheath through which a deployment catheter and imaging hood may be advanced for placement against or adjacent to the tissue to be imaged.
- The deployment catheter may define a fluid delivery lumen therethrough as well as an imaging lumen within which an optical imaging fiber or electronic imaging assembly may be disposed for imaging tissue. When deployed, the imaging hood may be expanded into any number of shapes, e.g., cylindrical, conical, semi-spherical, etc., provided that an open area or field is defined by the imaging hood. The open area is the area within which the tissue region of interest may be imaged and which is also defined in part by the contacted tissue region as well. The imaging hood may also define an atraumatic contact lip or edge for placement or abutment, against the tissue region of interest. Moreover, the distal end of the deployment catheter or separate manipulatable catheters may be articulated through various controlling mechanisms such as push-pull wires manually or via computer control
- The deployment catheter may also be stabilized relative to the tissue surface through various methods. For instance, inflatable stabilizing balloons positioned along a length of the catheter may be utilized, or tissue engagement anchors may be passed through or along the deployment catheter for temporary engagement of the underlying tissue.
- In operation, after the imaging hood has been deployed, fluid may be pumped at a positive pressure through the fluid delivery lumen until the fluid fills the open, area completely and displaces any blood from within the open area. The fluid may comprise any biocompatible fluid, e.g., saline, water, plasma, Fluorinert™, etc., which is sufficiently transparent to allow for relatively undistorted visualization through the fluid. The fluid may be pumped continuously or intermittently to allow for image capture by an optional processor which may be in communication with the assembly.
- The imaging hood, may be formed into any number of configurations and the imaging assembly may also be utilized with any number of therapeutic tools, such as tissue ablation instruments, which may be deployed through the deployment catheter. One particular variation may employ an imaging hood having a tissue anchor deployable therethrough and into a portion of a body lumen such as the pulmonary vein. Once the anchor has been temporarily deployed and secured within the pulmonary vein, the hood and ablation instrument may be articulated around a circumference of the vein ostium or several ostia where the tissue may be ablated in a controlled and consistent manner to electrically isolate the tissue such that a conduction block is created.
- While the imaging hood is moved around the tissue with the anchor deployed and secured distally within the pulmonary vein, the imaging hood may be articulated such that blood flow through the pulmonary vein is unobstructed or uninhibited by the hood.
- The tissue surrounding the ostium may be visualized via the imaging hood prior to, during, or after the ablation to ensure that the appropriate tissue is suitably ablated for treating conditions such as atrial fibrillation. The distally located anchor which secures a relative position of the imaging hood with respect to the tissue may be maintained until the procedure is completed. After completion, the anchor may be at least partially withdrawn into the imaging hood or reconfigured into a low-profile shape to disengage the tissue and allow the imaging hood to be removed or repositioned in the patient body.
-
FIG. 1A shows a side view of one variation of a tissue imaging apparatus during deployment from a sheath or delivery catheter. -
FIG. 1B shows the deployed tissue imaging apparatus ofFIG. 1A having an optionally expandable hood or sheath attached to an imaging and/or diagnostic catheter. -
FIG. 1C shows an end view of a deployed imaging apparatus. -
FIGS. 1D to 1F show the apparatus ofFIGS. 1A to 1C with an additional lumen, e.g., for passage of a guidewire therethrough. -
FIGS. 2A and 2B show one example of a deployed tissue imager positioned against or adjacent to the tissue to be imaged and a flow of fluid, such as saline, displacing blood from within the expandable hood. -
FIG. 3A shows an articulatable imaging assembly which may be manipulated via push-pull wires or by computer control. -
FIGS. 3B and 3C show steerable instruments, respectively, where an articulatable delivery catheter maybe steered within the imaging hood or a distal portion of the deployment catheter itself may be steered. -
FIGS. 4A to 4C show side and cross-sectional end views, respectively, of another variation having an off-axis imaging capability. -
FIGS. 4D and 4E show examples of various visualization imagers which may be utilized within or along the imaging hood. -
FIG. 5 shows an illustrative view of an example of a tissue imager advanced intravascularly within a heart for imaging tissue regions within an atrial chamber. -
FIGS. 6A to 6C illustrate deployment catheters having one or more optional inflatable balloons or anchors for stabilizing the device during a procedure. -
FIGS. 7A and 7B illustrate a variation of an anchoring mechanism such as a helical tissue piercing device for temporarily stabilizing the imaging hood relative to a tissue surface. -
FIG. 7C shows another variation for anchoring the imaging hood having one or more tubular support members integrated with the imaging hood; each support members may define a lumen therethrough for advancing a helical tissue anchor within. -
FIG. 8A shows an illustrative example of one variation of how a tissue imager may be utilized with an imaging device. -
FIG. 8B shows a further illustration of a hand-held variation of the fluid delivery and tissue manipulation system. -
FIGS. 9A to 9C illustrate an example of capturing several images of the tissue at multiple regions. -
FIGS. 10A and 10B show charts illustrating how fluid pressure within the imaging hood may be coordinated with the surrounding blood pressure; the fluid pressure in the imaging hood may be coordinated with the blood pressure or it may be regulated based upon pressure feedback from the blood. -
FIGS. 11A and 11B show side and end views, respectively, of a hood and catheter engaging and visualizing the pulmonary vein ostium while temporarily tethered via a deployable anchor positioned within the pulmonary vein such that blood flow through the pulmonary vein is unobstructed. -
FIGS. 12A and 12B show side and end views, respectively, of the hood and catheter articulated around the pulmonary vein ostium while ablating and/or visualizing the underlying tissue. -
FIGS. 13A to 13C show end views of the device with the pulmonary vein anchor acting as a guide to ensure hood stability while the hood is articulated circumferentially along the pulmonary vein ostium while leaving the blood flow through the ostium unimpeded. -
FIGS. 14A and 14B show partial cross-sectional side views of a helical anchor constrained in its low-profile configuration within a cylindrical sheath and deployed in its expanded and unconstrained configuration. -
FIG. 14C shows a partial cross-sectional side view of the helical anchor temporarily secured within the pulmonary vein while allowing for blood flow through the vessel to continue unimpeded or unobstructed. -
FIGS. 15A and 15B show partial cross-sectional side views of a basket anchor constrained in its low-profile configuration within a cylindrical sheath and deployed in its expanded and unconstrained configuration. -
FIG. 15C shows a partial cross-sectional side view of the basket anchor temporarily secured within the pulmonary vein while allowing for blood flow through the vessel to continue unimpeded or unobstructed. -
FIGS. 16A and 16B show partial cross-sectional side views of a mesh anchor constrained in its low-profile configuration within a cylindrical sheath and deployed in its expanded and unconstrained configuration. -
FIG. 16C shows a partial cross-sectional side view of the mesh anchor temporarily secured within the pulmonary vein while allowing for blood flow through the vessel to continue unimpeded or unobstructed. -
FIGS. 17A and 17B show side views of an inflatable balloon anchor assembly in its low profile configuration and its inflated configuration, respectively, where the assembly is expandable into a staggered configuration such that blood may still flow unobstructed past the inflated balloons. -
FIGS. 18A and 18B show a variation of the tissue visualization catheter having a reconfigurable flap which is configured to pivot about the contact lip or edge of the hood from its low profile configuration to its extended configuration, respectively. -
FIGS. 19A and 19B show perspective views of the device ofFIGS. 18A and 18B with the flap shown in its low profile and extended configurations, respectively. -
FIG. 20 shows a side view of the hood having the flap deployed and engaged along the PV ostium to act as a guide for articulating the hood circumferentially. -
FIGS. 21A to 21C show end views of the catheter and hood having the deployed flap engaged along the pulmonary vein ostium such that the blood flow through the vessel is unimpeded while circumferentially ablating the underlying tissue under direct visualization. -
FIG. 22 shows a perspective view of another variation having an anchor extending from a side port for deployment within the vessel lumen. -
FIGS. 23A and 23B show perspective and end views, respectively, of the anchor engaged within a first pulmonary vein while the tissue around adjacent ostia are ablated in an encircling lesion to electrically isolate the vessels. - A tissue-imaging and manipulation apparatus described below is able to provide real-time images in vivo of tissue regions within a body lumen such as a heart, which is filled with blood flowing dynamically therethrough and is also able to provide intravascular tools and instruments for performing various procedures upon the imaged tissue regions. Such an apparatus may be utilized for many procedures, e.g., facilitating transseptal access to the left atrium, cannulating the coronary sinus, diagnosis of valve regurgitation/stenosis, valvuloplasty, atrial appendage closure, arrhythmogenic focus ablation, among other procedures. Further examples of tissue visualization catheters which may be utilized are shown and described in further detail in U.S. patent application Ser. No. 11/259,498 filed Oct. 25, 2005, which has been incorporated hereinabove by reference in its entirety.
- One variation of a tissue access and imaging apparatus is shown in the detail perspective views of
FIGS. 1A to 1C . As shown inFIG. 1A , tissue imaging andmanipulation assembly 10 may be delivered intravascularly through the patient's body in a low-profile configuration via a delivery catheter orsheath 14. In the case of treating tissue, such as the mitral valve located at the outflow tract of the left atrium of the heart, it is generally desirable to enter or access the left atrium while minimizing trauma to the patient. To non-operatively effect such access, one conventional approach involves puncturing the intra-atrial septum from the right atrial chamber to the left atrial chamber in a procedure commonly called a transseptal procedure or septostomy. For procedures such as percutaneous valve repair and replacement, transseptal access to the left atrial chamber of the heart may allow for larger devices to be introduced into the venous system than can generally be introduced percutaneously into the arterial system. - When the imaging and
manipulation assembly 10 is ready to be utilized for imaging tissue,imaging hood 12 may be advanced relative tocatheter 14 and deployed from a distal opening ofcatheter 14, as shown by the arrow. Upon deployment,imaging hood 12 may be unconstrained to expand or open into a deployed imaging configuration, as shown inFIG. 1B .Imaging hood 12 may be fabricated from a variety of pliable or conformable biocompatible material including but not limited to, e.g., polymeric, plastic, or woven materials. One example of a woven material is Kevlar® (E. I. du Pont de Nemours, Wilmington, Del.), which is an aramid and which can be made into thin, e.g., less than 0.001 in., materials which maintain enough integrity for such applications described herein. Moreover, theimaging hood 12 may be fabricated from a translucent or opaque material and in a variety of different colors to optimize or attenuate any reflected lighting from surrounding fluids or structures, i.e., anatomical or mechanical structures or instruments. In either case, imaginghood 12 may be fabricated into a uniform structure or a scaffold-supported structure, in which case a scaffold made of a shape memory alloy, such as Nitinol, or a spring steel, or plastic, etc., may be fabricated and covered with the polymeric, plastic, or woven, material. Hence,imaging hood 12 may comprise any of a wide variety of barriers or membrane structures, as may generally be used to localize displacement of blood or the like from a selected volume of a body lumen or heart chamber. In exemplary embodiments, a volume within aninner surface 13 ofimaging hood 12 will be significantly less than a volume of thehood 12 betweeninner surface 13 andouter surface 11. -
Imaging hood 12 may be attached atinterface 24 to adeployment catheter 16 which may be translated independently of deployment catheter orsheath 14. Attachment ofinterface 24 may be accomplished through any number of conventional methods.Deployment catheter 16 may define afluid delivery lumen 18 as well as animaging lumen 20 within which an optical imaging fiber or assembly may be disposed for imaging tissue. When deployed,imaging hood 12 may expand into any number of shapes, e.g., cylindrical, conical as shown, semi-spherical, etc., provided that an open area orfield 26 is defined by imaginghood 12. Theopen area 26 is the area within which the tissue region of interest may be imaged.Imaging hood 12 may also define an atraumatic contact lip or edge 22 for placement or abutment against the tissue region of interest. Moreover, the diameter ofimaging hood 12 at its maximum fully deployed diameter, e.g., at contact lip oredge 22, is typically greater relative to a diameter of the deployment catheter 16 (although a diameter of contact lip or edge 22 may be made to have a smaller or equal diameter of deployment catheter 16). For instance, the contact edge diameter may range anywhere from 1 to 5 times (or even greater, as practicable) a diameter ofdeployment catheter 16.FIG. 1C shows an end view of theimaging hood 12 in its deployed configuration. Also shown are the contact lip or edge 22 andfluid delivery lumen 18 andimaging lumen 20. - The imaging and
manipulation assembly 10 may additionally define a guidewire lumen therethrough, e.g., a concentric or eccentric lumen, as shown in the side and end views, respectively, ofFIGS. 1D to 1F . Thedeployment catheter 16 may defineguidewire lumen 19 for facilitating the passage of the system over or along aguidewire 17, which may be advanced intravascularly within a body lumen. Thedeployment catheter 16 may then be advanced over theguidewire 17, as generally known in the art. - In operation, alter
imaging hood 12 has been deployed, as inFIG. 1B , and desirably positioned against the tissue region to be imaged alongcontact edge 22, the displacing fluid may be pumped at positive pressure throughfluid delivery lumen 18 until the fluid fillsopen area 26 completely and displaces any fluid 28 from withinopen area 26. The displacing fluid flow may be laminarized to improve its clearing effect and to help prevent blood from re-entering theimaging hood 12. Alternatively, fluid flow may be started before the deployment takes place. The displacing fluid, also described herein as imaging fluid, may comprise any biocompatible fluid, e.g., saline, water, plasma, etc., which is sufficiently transparent to allow for relatively undistorted visualization through the fluid. Alternatively or additionally, any number of therapeutic drugs may be suspended within the fluid or may comprise the fluid itself which is pumped intoopen area 26 and which is subsequently passed into and through the heart and the patient body. - As seen in the example of
FIGS. 2A and 2B ,deployment catheter 16 may be manipulated to position deployedimaging hood 12 against or near the underlying tissue region of interest to be imaged, in this example a portion of annulus A of mitral valve MV within the left atrial chamber. As the surroundingblood 30 flows aroundimaging hood 12 and withinopen area 26 defined withinimaging hood 12, as seen inFIG. 2A , the underlying annulus A is obstructed by theopaque blood 30 and is difficult to view through theimaging lumen 20. Thetranslucent fluid 28, such as saline, may then be pumped throughfluid delivery lumen 18, intermittently or continuously, until theblood 30 is at least partially, and preferably completely, displaced from withinopen area 26 byfluid 28, as shown inFIG. 2B . - Although contact, edge 22 need not directly contact the underlying tissue, it is at least preferably brought into close proximity to the tissue such that the flow of
clear fluid 28 fromopen area 26 may be maintained to inhibit significant backflow ofblood 30 bade intoopen area 26.Contact edge 22 may also be made of a soft elastomeric material such as certain soft grades of silicone or polyurethane, as typically known, to help contactedge 22 conform to an uneven or rough underlying anatomical tissue surface. Once theblood 30 has been displaced from imaginghood 12, an image may then be viewed of the underlying tissue through theclear fluid 30. This image may then be recorded or available for real-time viewing for performing a therapeutic procedure. The positive flow offluid 28 may be maintained continuously to provide for clear viewing of the underlying tissue. Alternatively, the fluid 28 may be pumped, temporarily or sporadically only until a clear view of the tissue is available to be imaged and recorded, at which point thefluid flow 28 may cease andblood 30 may be allowed to seep or flow back intoimaging hood 12. This process may be repeated a number of times at the same tissue region or at multiple tissue regions. - In desirably positioning the assembly at various regions within the patient body, a number of articulation and manipulation controls may be utilized. For example, as shown in the
articulatable imaging assembly 40 inFIG. 3A , one or more push-pull wires 42 may be routed throughdeployment catheter 16 for steering the distal end portion of the device invarious directions 46 to desirably position theimaging hood 12 adjacent to a region of tissue to be visualized. Depending upon the positioning and the number of push-pull wires 42 utilized,deployment catheter 16 andimaging hood 12 may be articulated into any number ofconfigurations 44. The push-pull wire orwires 42 may be articulated via their proximal ends from outside the patient body manually utilizing one or more controls. Alternatively,deployment catheter 16 may be articulated by computer control, as further described below. - Additionally or alternatively, an
articulatable delivery catheter 48, which may be articulated via one or more push-pull wires and having an imaging lumen and one or more working lumens, may be delivered through thedeployment catheter 16 and intoimaging hood 12. With a distal portion ofarticulatable delivery catheter 48 withinimaging hood 12, the clear displacing fluid may be pumped throughdelivery catheter 48 ordeployment catheter 16 to clear the field withinimaging hood 12. As shown inFIG. 3B , thearticulatable delivery catheter 48 may be articulated within the imaging hood to obtain a better image of tissue adjacent to theimaging hood 12. Moreover,articulatable delivery catheter 48 may be articulated to direct an instrument or tool passed through thecatheter 48, as described in detail below, to specific areas of tissue imaged throughimaging hood 12 without having to repositiondeployment catheter 16 and re-clear the imaging field withinhood 12. - Alternatively, rather than passing an
articulatable delivery catheter 48 through thedeployment catheter 16, a distal portion of thedeployment catheter 16 itself may comprise adistal end 49 which is articulatable withinimaging hood 12, as shown inFIG. 3C . Directed imaging, instrument delivery, etc., may be accomplished directly through one or more lumens withindeployment catheter 16 to specific regions of the underlying tissue imaged withinimaging hood 12. - Visualization within the
imaging hood 12 may be accomplished through animaging lumen 20 defined throughdeployment catheter 16, as described above. In such a configuration, visualization is available in a straight-line manner, i.e., images are generated from the field distally along a longitudinal axis defined by thedeployment catheter 16. Alternatively or additionally, an articulatable imaging assembly having apivotable support member 50 may be connected to, mounted to, or otherwise passed throughdeployment catheter 16 to provide for visualization off-axis relative to the longitudinal axis defined bydeployment catheter 16, as shown inFIG. 4A .Support member 50 may have animaging element 52, e.g., a CCD or CMOS imager or optical fiber, attached at its distal end with its proximal end connected todeployment catheter 16 via apivoting connection 54. - If one or more optical fibers are utilized for imaging, the
optical fibers 58 may be passed throughdeployment catheter 16, as shown in the cross-section ofFIG. 4B , and routed through thesupport member 50. The use ofoptical fibers 58 may provide for increased diameter sizes of the one orseveral lumens 56 throughdeployment catheter 16 for the passage of diagnostic and/or therapeutic tools therethrough. Alternatively, electronic chips, such as a charge coupled device (CCD) or a CMOS imager, which are typically known, may be utilized in place of theoptical fibers 58, in which case the electronic imager may be positioned in the distal portion of thedeployment catheter 16 with electric wires being routed proximally through thedeployment catheter 16. Alternatively, the electronic imagers may be wirelessly coupled to a receiver for the wireless transmission of images. Additional optical fibers or light emitting diodes (LEDs) can be used to provide lighting for the image or operative theater, as described below in further detail.Support member 50 may be pivoted viaconnection 54 such that themember 50 can be positioned in a low-profile configuration within channel or groove 60 defined in a distal portion ofcatheter 16, as shown in the cross-section ofFIG. 4C . During intravascular delivery ofdeployment catheter 16 through the patient body,support member 50 can be positioned within channel or groove 60 withimaging hood 12 also in its low-profile configuration. During visualization,imaging hood 12 may be expanded into its deployed configuration andsupport member 50 may be deployed into its off-axis configuration for imaging the tissue adjacent tohood 12, as inFIG. 4A . Other configurations forsupport member 50 for off-axis visualization may be utilized, as desired. -
FIG. 4D shows a partial cross-sectional view of an example where one or moreoptical fiber bundles 62 may be positioned within the catheter and withinimaging hood 12 to provide direct in-line imaging of the open area withinhood 12.FIG. 4E shows another example where an imaging element 64 (e.g., CCD or CMOS electronic imager) may be placed along an interior surface ofimaging hood 12 to provide imaging of the open area such that theimaging element 64 is off-axis relative to a longitudinal axis of thehood 12. The off-axis position ofelement 64 may provide for direct visualization and uninhibited access by instruments from the catheter to the underlying tissue during treatment. -
FIG. 5 shows an illustrative cross-sectional view of a heart H having tissue regions of interest being viewed via animaging assembly 10. In this example,delivery catheter assembly 70 may be introduced percutaneously into the patient's vasculature and advanced through the superior vena cava SVC and into the right atrium RA. The delivery catheter orsheath 72 may be articulated through the atrial septum AS and into the left atrium LA for viewing or treating the tissue, e.g., the annulus A, surrounding the mitral valve MV. As shown,deployment catheter 16 andimaging hood 12 may be advanced out ofdelivery catheter 72 and brought into contact or in proximity to the tissue region of interest. In other examples,delivery catheter assembly 70 may be advanced through the inferior vena cava IVC, if so desired. Moreover, other regions of the heart H, e.g., the right ventricle RV or left ventricle LV, may also be accessed and imaged or treated by imagingassembly 10. - In accessing regions of the heart H or other parts of the body, the delivery catheter or
sheath 14 may comprise a conventional intra-vascular catheter or an endoluminal delivery device. Alternatively, robotically-controlled delivery catheters may also be optionally utilized with the imaging assembly described herein, in which case a computer-controller 74 may be used to control the articulation and positioning of thedelivery catheter 14. An example of a robotically-controlled delivery catheter which may be utilized is described in further detail in US Pat. Pub. 2002/0087169 A1 to Brock et al. entitled “Flexible Instrument”, which is incorporated herein by reference in its entirety. Other robotically-controlled delivery catheters manufactured by Hansen Medical, Inc. (Mountain View, Calif.) may also be utilized with thedelivery catheter 14. - To facilitate stabilization of the
deployment catheter 16 during a procedure, one or more inflatable balloons or anchors 76 may be positioned along the length ofcatheter 16, as shown inFIG. 6A . For example, when utilizing a transseptal approach across the atrial septum AS into the left atrium LA, theinflatable balloons 76 may be inflated from a low-profile into their expanded configuration to temporarily anchor or stabilize thecatheter 16 position relative to the heart H.FIG. 6B shows afirst balloon 78 inflated whileFIG. 6C also shows asecond balloon 80 inflated proximal to thefirst balloon 78. In such a configuration, the septal wall AS may be wedged or sandwiched between theballoons catheter 16 andimaging hood 12. Asingle balloon 78 or bothballoons balloon assembly 76 may be deflated or re-configured into a low-profile for removal of thedeployment catheter 16. - To further stabilize a position of the
imaging hood 12 relative to a tissue surface to be imaged, various anchoring mechanisms may be optionally employed for temporarily holding theimaging hood 12 against the tissue. Such anchoring mechanisms may be particularly useful for imaging tissue which is subject to movement, e.g., when imaging tissue within the chambers of a beating heart. Atool delivery catheter 82 having at least one instrument lumen and an optional visualization lumen may be delivered throughdeployment catheter 16 and into an expandedimaging hood 12. As theimaging hood 12 is brought into contact against a tissue surface T to be examined, anchoring mechanisms such as a helicaltissue piercing device 84 may be passed through thetool delivery catheter 82, as shown inFIG. 7A , and intoimaging hood 12. - The helical
tissue engaging device 84 may be torqued from its proximal end outside the patient body to temporarily anchor itself into the underlying tissue surface T. Once embedded within the tissue T, the helicaltissue engaging device 84 may be pulled proximally relative todeployment catheter 16 while thedeployment catheter 16 andimaging hood 12 are pushed distally, as indicated by the arrows inFIG. 7B , to gently force the contact edge orlip 22 of imaging hood against the tissue T. The positioning of thetissue engaging device 84 may be locked temporarily relative to thedeployment catheter 16 to ensure secure positioning of theimaging hood 12 during a diagnostic or therapeutic procedure within theimaging hood 12. After a procedure,tissue engaging device 84 may be disengaged from the tissue by torquing its proximal end in the opposite direction to remove the anchor form the tissue T and thedeployment catheter 16 may be repositioned to another region of tissue where the anchoring process may be repeated or removed from the patient body. Thetissue engaging device 84 may also be constructed from other known tissue engaging devices such as vacuum-assisted engagement or grasper-assisted engagement tools, among others. - Although a
helical anchor 84 is shown, this is intended to be illustrative and other types of temporary anchors may be utilized, e.g., hooked or barbed anchors, graspers, etc. Moreover, thetool delivery catheter 82 may be omitted entirely and the anchoring device may be delivered directly through a lumen defined through thedeployment catheter 16. - In another variation where the tool,
delivery catheter 82 may be omitted entirely to temporarily anchorimaging hood 12.FIG. 7C shows animaging hood 12 having one or moretubular support members 86, e.g., foursupport members 86 as shown, integrated with theimaging hood 12. Thetubular support members 86 may define lumens therethrough each having helicaltissue engaging devices 88 positioned within. When an expandedimaging hood 12 is to be temporarily anchored to the tissue, the helicaltissue engaging devices 88 may be urged distally to extend from imaginghood 12 and each may be torqued from its proximal end to engage the underlying tissue T. Each of the helicaltissue engaging devices 88 may be advanced through the length ofdeployment catheter 16 or they may be positioned withintubular support members 86 during the delivery and deployment ofimaging hood 12. Once the procedure withinimaging hood 12 is finished, each of thetissue engaging devices 88 may be disengaged from the tissue and theimaging hood 12 may be repositioned to another region of tissue or removed from the patient body. - An illustrative example is shown in
FIG. 8A of a tissue imaging assembly connected to afluid delivery system 90 and to anoptional processor 98 and image recorder and/orviewer 100. Thefluid delivery system 90 may generally comprise apump 92 and anoptional valve 94 for controlling the flow rate of the fluid into the system. Afluid reservoir 96, fluidly connected to pump 92, may hold the fluid to be pumped throughimaging hood 12. An optional central processing unit orprocessor 98 may be in electrical communication withfluid delivery system 90 for controlling flow parameters such as the flow rate and/or velocity of the pumped fluid. Theprocessor 98 may also be in electrical communication with an image recorder and/orviewer 100 for directly viewing the images of tissue received from withinimaging hood 12. Imager recorder and/orviewer 100 may also be used not only to record the image but also the location of the viewed tissue region, if so desired. - Optionally,
processor 98 may also be utilized to coordinate the fluid flow and the image capture. For instance,processor 98 may be programmed to provide for fluid flow fromreservoir 96 until the tissue area has been displaced of blood to obtain a clear image. Once the image has been determined to be sufficiently clear, either visually by a practitioner or by computer, an image of the tissue may be captured automatically byrecorder 100 and pump 92 may be automatically stopped or slowed byprocessor 98 to cease the fluid flow into the patient. Other variations for fluid delivery and image capture are, of course, possible and the aforementioned configuration is intended only to be illustrative and not limiting. -
FIG. 8B shows a further illustration of a hand-held variation of the fluid delivery andtissue manipulation system 110. In this variation,system 110 may have a housing or handleassembly 112 which can be held or manipulated by the physician from outside the patient body. Thefluid reservoir 114, shown in this variation as a syringe, can be fluidly coupled to thehandle assembly 112 and actuated via apumping mechanism 116, e.g., lead screw.Fluid reservoir 114 may be a simple reservoir separated from thehandle assembly 112 and fluidly coupled to handleassembly 112 via one or more tubes. The fluid flow rate and other mechanisms may be metered by theelectronic controller 118. - Deployment of
imaging hood 12 may be actuated by ahood deployment switch 120 located on thehandle assembly 112 while dispensation of the fluid fromreservoir 114 may be actuated by afluid deployment switch 122, which can be electrically coupled to thecontroller 118.Controller 118 may also be electrically coupled to a wired orwireless antenna 124 optionally integrated with thehandle assembly 112, as shown in the figure. Thewireless antenna 124 can be used to wirelessly transmit images captured from theimaging hood 12 to a receiver, e.g., via Bluetooth® wireless technology (Bluetooth SIG, Inc., Bellevue, Wash.), RF, etc., for viewing on amonitor 128 or for recording for later viewing. - Articulation control of the
deployment catheter 16, or a delivery catheter orsheath 14 through which thedeployment catheter 16 may be delivered, may be accomplished by computer control as described above, in which case an additional controller may be utilized withhandle assembly 112. In the ease of manual articulation, handleassembly 112 may incorporate one or more articulation controls 126 for manual manipulation of the position ofdeployment catheter 16.Handle assembly 112 may also define one ormore instrument ports 130 through which a number of intravascular tools may be passed for tissue manipulation and treatment withinimaging hood 12, as described further below. Furthermore, in certain procedures, fluid or debris may be sucked intoimaging hood 12 for evacuation from the patient body by optionally fluidly coupling asuction pump 132 to handleassembly 112 or directly todeployment catheter 16. - As described above, fluid may be pumped continuously into
imaging hood 12 to provide for clear viewing of the underlying tissue. Alternatively, fluid may be pumped temporarily or sporadically only until a clear view of the tissue is available to be imaged and recorded, at which point the fluid flow may cease and the blood may be allowed to seep or flow back intoimaging hood 12.FIGS. 9A to 9C illustrate an example of capturing several images of the tissue at multiple regions.Deployment catheter 16 may be desirably positioned andimaging hood 12 deployed and brought into position against a region of tissue to be imaged, in this example the tissue surrounding a mitral valve MY within the left atrium of a patient's heart. Theimaging hood 12 may be optionally anchored to the tissue, as described above, and then cleared by pumping the imaging fluid into thehood 12. Once sufficiently clear, the tissue may be visualized and the image captured bycontrol electronics 118. The first capturedimage 140 may be stored and/or transmitted wirelessly 124 to amonitor 128 for viewing by the physician, as shown inFIG. 9A . - The
deployment catheter 16 may be then repositioned to an adjacent portion of mitral valve MV, as shown inFIG. 9B , where the process may be repeated to capture asecond image 142 for viewing and/or recording. Thedeployment catheter 16 may again be repositioned to another region of tissue, as shown inFIG. 9C , where athird image 144 may be captured for viewing and/or recording. This procedure may be repeated as many times as necessary for capturing a comprehensive image of the tissue surrounding mitral valve MV, or any other tissue region. When thedeployment catheter 16 andimaging hood 12 is repositioned from tissue region to tissue region, the pump may be stopped during positioning and blood or surrounding fluid may be allowed to enter withinimaging hood 12 until the tissue is to be imaged, where theimaging hood 12 may be cleared, as above. - As mentioned above, when the
imaging hood 12 is cleared by pumping the imaging fluid within for clearing the blood or other bodily fluid, the fluid may be pumped continuously to maintain the imaging fluid within thehood 12 at a positive pressure or it may be pumped under computer control for slowing or stopping the fluid flow into thehood 12 upon detection of various parameters or until a clear image of the underlying tissue is obtained. Thecontrol electronics 118 may also be programmed to coordinate the fluid flow into theimaging hood 12 with various physical parameters to maintain a clear image withinimaging hood 12. - One example is shown in
FIG. 10A which shows achart 150 illustrating how fluid pressure within theimaging hood 12 may be coordinated with the surrounding blood pressure. Chart 150 shows thecyclical blood pressure 156 alternating betweendiastolic pressure 152 andsystolic pressure 154 over time T due to the beating motion of the patient heart. The fluid pressure of the imaging fluid, indicated byplot 160, withinimaging hood 12 may be automatically timed to correspond to the blood pressure changes 160 such that an increased pressure is maintained withinimaging hood 12 which is consistently above theblood pressure 156 by a slight increase ΔP, as illustrated by the pressure difference at the peaksystolic pressure 158. This pressure difference, ΔP, may be maintained withinimaging hood 12 over the pressure variance of the surrounding blood pressure to maintain a positive imaging fluid pressure withinimaging hood 12 to maintain a clear view of the underlying tissue. One benefit of maintaining a constant ΔP is a constant flow and maintenance of a clear field. -
FIG. 10B shows achart 162 illustrating another variation for maintaining a clear view of the underlying tissue where one or more sensors within theimaging hood 12, as described in further detail below, may be configured to sense pressure changes within theimaging hood 12 and to correspondingly increase the imaging fluid pressure withinimaging hood 12. This may result in a time delay, ΔT, as illustrated by the shiftedfluid pressure 160 relative to thecycling blood pressure 156, although the time delays ΔT may be negligible in maintaining the clear image of the underlying tissue. Predictive software algorithms can also be used to substantially eliminate this time delay by predicting when the next pressure wave peak will arrive and by increasing the pressure ahead of the pressure wave's arrival by an amount of time equal to the aforementioned time delay to essentially cancel the time delay out. - The variations in fluid pressure within
imaging hood 12 may be accomplished in part due to the nature ofimaging hood 12. An inflatable balloon, which is conventionally utilized for imaging tissue, may be affected by the surrounding blood pressure changes. On the other hand, animaging hood 12 retains a constant volume therewithin and is structurally unaffected by the surrounding blood pressure changes, thus allowing for pressure increases therewithin. The material thathood 12 is made from may also contribute to the manner in which the pressure is modulated within thishood 12. A stiller hood material, such as high durometer poly urethane or Nylon, may facilitate the maintaining of an open hood when deployed. On the other hand, a relatively lower durometer or softer material, such as a low durometer PVC or polyurethane, may collapse from the surrounding fluid pressure and may not adequately maintain a deployed or expanded hood. - The imaging hood itself may be formed into any number of configurations and the imaging assembly may also be utilized with any number of therapeutic tools, such as tissue ablation instruments, which may be deployed through the deployment catheter. One particular variation may employ an imaging hood having a tissue anchor deployable therethrough and into a portion of a body lumen such as the pulmonary vein. Once the anchor has been temporarily deployed and secured within the pulmonary vein, the hood and ablation instrument may be articulated around a circumference of the vein ostium or several ostia where the tissue may be ablated in a controlled and consistent manner to electrically isolate the tissue such that a conduction block is created.
- Generally, while the imaging hood is moved around the tissue with the anchor deployed and secured distally within the pulmonary vein, the imaging hood may be articulated such that blood flow through the pulmonary vein is unobstructed or uninhibited by the hood. The tissue surrounding the ostium may be visualized via the imaging hood prior to, during, or after the ablation to ensure that the appropriate tissue is suitably ablated for treating conditions such as atrial fibrillation. The distally located anchor which secures a relative position of the imaging hood with respect to the tissue may be maintained until the procedure is completed. After completion, the anchor may be at least partially withdrawn into the imaging hood or reconfigured into a low-profile shape to disengage the tissue and allow the imaging hood to be removed or repositioned in the patient body.
- Turning now to
FIGS. 11A and 11B , which show respective side and end views ofvisualization hood 12 placed against and visualizing a portion of the ostium, e.g., the ostium OSLS of the left superior pulmonary vein PVLS. Placement and movement ofhood 12 about ostium OSLS may be facilitated by the deployment and placement of an anchor within the respective pulmonary vein while tethered tohood 12 orcatheter 16. Generally, the anchor situated within the pulmonary vein may be sufficiently open such that the anchor does not obstruct blood flow through the pulmonary vein. Although the examples illustrate placement of the anchors within the left, superior pulmonary vein PVLS and ablation or treatment of the respective left superior ostium OSLS, this is intended to be illustrative and anchoring within the other pulmonary veins and other vessels and/or treatment of the respective ostia are included within the scope of this disclosure. - In this example, the pulmonary vein anchor may be configured as a
helical anchor 170 which is attached to ananchor member 172, e.g., a guidewire, such thathelical anchor 170 may be advanced throughdelivery catheter 16 in a low-profile configuration and then slowly expanded when advanced distally out ofcatheter 16. Ashelical anchor 170 expands,anchor member 170 may be advanced distally within the pulmonary vein untilanchor 170 is expanded into contact against the wall of the pulmonary vein, as shown inFIG. 11A . Alternatively, a deployment sheath may be advanced through a working channel ofdeployment catheter 16, throughhood 12, and distally into the pulmonary vein. When the deployment sheath is desirably situated within the pulmonary vein,helical anchor 170 may be advanced distally and/or the sheath may be retracted proximally to deploy and expand theanchor 170.Anchor 170 is described in further detail below. - With
helical anchor 170 secured within the pulmonary vein,hood 12 may be placed into contact against a portion of ostium OSLS by pushinghood 12 alonganchor member 172 distally in the direction towardsanchor 170 untilhood 12 is pressed against the tissue surface. Once pressed against the tissue surface, thetransparent purging fluid 28 may be pumped into open area orfield 26 to enable direct visualization of the tissue surrounding ostium OSLS while surrounded byblood 30. - As previously mentioned
unobstructed blood flow 178 may continue through the pulmonary vein PVLS pastanchor 170 because of its non-obstructive configuration while thetissue underlying hood 12 is visualized byimaging element 176, e.g., CCD, CMOS, or optical fiber, etc., positioned upon or alonghood 12 or withincatheter 16. Unlike an anchoring balloon where an entire inflated balloon potentially blocks the pulmonary vein and deprives the heart of oxygenated blood from the pulmonary vein,anchor 170 is able to be secured, against the vessel wall without blocking the vessel lumen. Unobstructed blood flow is further facilitated by positioning thehood 12 laterally relative to the ostium OSLS such that the vessel opening remains minimally obstructed or completely unobstructed, as shown inFIG. 11B . - By maintaining contact between
hood 12 and the tissue surrounding OSLS, an instrument such asablation probe 174 may be advanced withinhood 12 and placed into contact against or in proximity to the underlying tissue which may be ablated while under direct visualization viaimaging element 176.Ablation probe 174 may ablate the tissue immediately underlyinghood 12 andhood 12 may then be repositioned over an adjacent region of tissue to be ablated where the process may be repeated. Alternatively,hood 12 may be moved circumferentially about ostium OSLS while ablating the underlying tissue in a continuous manner. In either case,anchor member 172 may act as a guide to ensure thathood 12 stays or tracks circumferentially around ostium OSLS during ablation. As shown in the side and end views ofFIGS. 12A and 12B , respectively, an example of howhood 12 may be moved around the ostium OSLS during ablation is illustrated wherehood 12 is moved in a counter-clockwise motion relative to ostium OSLS. Alternatively,hood 12 may be moved in a clockwise motion as well. By articulating or translating thehood 12 along the plane of the ostium OSLS at an angle away from the pulmonary vein PVLS,hood 12 may continue to capture a portion of the ostium OSLS asanchor 170 andanchor member 172 may confine the motion of thehood 12 to the circumference of the ostium OSLS. - As further illustrated in
FIG. 12B , a number ofdiscrete lesions 182 may be formed upon thetissue underlying hood 12. Repositioning ofhood 12 adjacent to the ablated tissue may allow for the creation of anotherdiscrete lesion 182 which may be overlapped upon one another such that a singlecontinuous lesion 180 is collectively formed. This process may be repeated until the desired circumference of tissue is ablated. Alternatively, thecontinuous lesion 180 may be formed while simultaneously ablating and movinghood 12 andablation probe 174 around ostium OSLS such that a single continuous line of tissue is ablated. In either case, the underlying tissue being ablated may be viewed under direct visualization fromimaging element 176. -
FIGS. 13A to 13C illustratehood 12 andablation probe 174 being constrained byanchor member 172 coupled to anchor 170 to follow a circumferential path around the ostium OSLS ashood 12 is articulated viacatheter 16. As previously mentioned, althoughhood 12 is illustrated following a counter-clockwise direction about OSLS,hood 12 may be articulated to follow a clockwise direction as well. Moreover,FIGS. 13A and 13B illustrateablation probe 174 being used to create a series of overlappingdiscrete lesions 182 to create acontinuous lesion 180 such that the entire circumference of tissue surrounding ostium OSLS is ablated to completely electrically isolate the ostium OSLS.FIG. 13C illustrates the resultinglesion 180 formed by the ablated tissue onceanchor 170 andanchor member 172 have been withdrawn andhood 12 has been removed from the ostium OSLS. Althoughlesion 180 is illustrated as encircling the entire circumference of ostium OSLS one or more discrete portions of the surrounding tissue may be ablated instead depending upon the desired results. Moreover, the circumference, or portions, of the circumference, of ostium OSLS may be ablated while under direct visualization withinhood 12 while allowing for obstructedblood flow 178 from the respective pulmonary vein. - As described above,
helical anchor 170 may be advanced through catheter 16.and throughhood 12 in a low-profile configuration while constrained either by a delivery lumen ofcatheter 16 or by anoptional anchor sheath 190 advanced through the delivery lumen while constraininganchor 170.FIG. 14A shows an example of anoptional anchor sheath 190 havinghelical anchor 170 extending fromanchor member 172 constrained withinanchor lumen 192 in its low-profile configuration. Whenhelical anchor 170 is to be deployed fromanchor lumen 192,anchor 170 may be advanced relative tosheath 190 and/orsheath 190 may be retracted relative to anchor 170 such thathelical anchor 170 may be extended beyondlumen 192 such thatanchor 170 is unconstrained and allowed to expand radially, as illustrated inFIG. 14B . - Once deployed within the vessel lumen, such as the pulmonary vein PVLS, as shown in the partial cross-sectional view of
FIG. 14C ,helical anchor 170 may be expanded or reconfigured such thatanchor 176 does not obstructblood flow 178 within the pulmonary vein PVLS. The expandedanchor 170 may provide engagement and orientation forhood 12 relative to the underlying tissue surrounding the ostium to conduct direct visualization and ablation of the tissue surrounding the ostium OSLS, as described above. Theanchor 170 may secure itself to the vessel wall by expanding laterally, e.g., perpendicularly relative to a longitudinal axis of theanchor 170, and applying a radial outward force upon the tissue walls of the vessel. Fractional contact between thehelical anchor 170 and the tissue surface may provide additional force to secure theanchor 170 in place. Thehelical anchor 170 can be formed from a wire made from a variety of materials, e.g., shape memory alloys such as Nitinol. When thehelical anchor 170 is retracted back intosheath 190, theanchor 170 may return to its original low-profile shape for repositioning or for removal from the patient. -
FIGS. 15A and 15B show partial cross-sectional views of another variation of the anchor for placement within the pulmonary vein where the anchor is configured as areconfigurable basket anchor 200 which is deliverable in its low-profile configuration wherebasket anchor 200 is constrained withinlumen 192 ofsheath 190, as shown inFIG. 15A , and deployable into an expanded or extended basket configuration, as shown inFIG. 15B . -
Basket anchor 200 may be formed to have several reconfigurable basket arms ormembers 206 which are each connected at adistal connection 202 and at aproximal connection 204.Basket anchor 200 may extend distally fromanchor member 208 such that distal movement of anchor member 208 (and/or proximal retraction of sheath 190) may urgebasket anchor 200 out oflumen 192 where basket arms ormembers 206 may expand laterally into its basket configuration, e.g., where arms ormembers 206 reconfigure perpendicularly relative to the axis of thebasket 200, and into contact against the vessel walls, as shown inFIG. 15C . Fractional contact between arms ormembers 206 and the tissue surface in contact provides additional force to secure theanchor 200 in place. Even in its expanded configuration,basket anchor 200 may provide an open pathway forblood flow 178 to continue relatively unobstructed between the arms ormembers 206 and through the vessel. - As above,
basket anchor 200 can be fabricated from shape memory alloy tubing such as Nitinol or from metal wires or ribbons such as stainless steel, titanium, etc. When retracted proximally back intosheath 190, thebasket anchor 200 may return to its original low-profile shape for repositioning within the same or different vessel or for removal from the patient. - In yet another variation,
FIGS. 16A and 16B show partial cross-sectional side views of an anchor configured as amesh anchor 210. Thismesh anchor 210 variation may anchor itself to the walls of the pulmonary vein PVLS by expanding laterally into a basket-like frame, e.g., perpendicularly relative to the longitudinal axis of theanchor 210, and applying a radial outward force on the wails of the vessel. Theanchor 210 may generally comprise multiple wire orribbon members 216 which are woven, interwoven, or interlaced with respect to one another to form the mesh which is connected at adistal connection 212 and aproximal connection 214 and attached, coupled, or otherwise extending fromanchor member 218. The wire orribbon members 216 can be formed from shape memory alloy such as Nitinol or from a polymeric of plastic material such as PET. When compressed into a low-profile cylindrical configuration and loaded in thelumen 192 ofsheath 190, as shown inFIG. 16A ,mesh anchor 210 may return to its expanded configuration by having wire orribbon members 216 expanded into the basket-like structure when, deployed fromsheath 190, as shown inFIG. 16B . Moreover, when deployed and secured against the vessel wall, as shown inFIG. 16C ,blood flow 178 may continue relatively unobstructed by flowing between themembers 216. - In yet another variation, the pulmonary vein anchor may be configured as a
balloon anchor assembly 220 having several balloon members which are inflatable into a staggered pattern for securement within the vessel. As shown inFIG. 17A , thestaggered balloon assembly 220 may be advanced at least partially within, e.g., the pulmonary vein PVLS, while in a deflated or low-profile configuration. Once desirably positioned, staggeredballoon anchor assembly 220 may be infused with a gas (such as nitrogen) or fluid (such as saline) viainflation lumen 228 to expand several balloons positioned in a staggered pattern along theinflation lumen 228. In this example, first offsetballoon 222 may be positioned distally alonglumen 228 while second offsetballoon 224 may be positioned proximally and in an offset position relative to first offsetballoon 222. A third offsetballoon 226 may be positioned proximally ofsecond balloon 224 such that it is offset with respect tosecond balloon 224 and/orfirst balloon 222, as illustrated inFIG. 17B . Although three balloon members are shown in this example, other variations may utilize two balloons or more than three balloons. Moreover, rather than having balloon members offset with respect to one another, balloon members may be configured into other shapes which still allow for blood flow through the vessel, e.g., one or more toroidal shaped balloon members. - Once the
balloon assembly 220 is inflated and secured within the vessel,blood flow 178 may continue through the pulmonary vein PVLS such that the blood is able to meander in an offsetflow pattern 230 past the staggered balloons. The staggered balloons can be made from a variety of materials typically utilized for biocompatible inflatable balloons, e.g., medical grade elastomers such as C-flex, chronoprene, silicone or polyurethane, etc. - In yet another variation, rather than utilizing a separately deployable anchor for placement within the vessel lumen.
FIGS. 18A and 18B show a variation of the tissue visualization catheter having areconfigurable flap 240 which is configured to pivot about the contact lip or edge 22 of thehood 12. In its low-profile configuration,flap 240 may remain folded inwardly along the inner wall of thehood 12. Aninflation lumen 246 may extend from thecatheter 16 along or within the wall of thehood 12 and terminate proximal to theflap 240 at an inflatable member orballoon 242 positioned betweenflap 240 andhood 12.Balloon 242 may be fabricated from a variety of materials, such as C-flex, chronoprene, polyurethane, etc. and it may be separately attached tohood 12 or it may optionally be integrated with the material ofhood 12. Upon injecting a fluid or gas throughlumen 246,balloon 242 may be inflated such thatflap 240 is lifted or rotated in thedirection 244 from its low-profile position along the inner wall ofhood 12, as shown inFIG. 18A , into its extended position, as shown inFIG. 18B . When theflap 240 is lifted passed an angle of approximately 25° or more relative to the lining ofhood 12, theflap 240 may be configured to flip open into its extended configuration.FIGS. 19A and 19B illustrate perspective views offlap 240 in its low-profile configuration and its extended configuration, respectively, corresponding toFIGS. 18A and 18B above. - In use,
flap 240 in its extended position may act as a guide for thehood 12 to trace the ostium OSLS to ensure thathood 12 moves along the circumference of the ostium OSLS. As illustrated in the side view ofFIG. 20 ,hood 12 may be positioned in proximity to the vessel and ostium to be treated. In this example,flap 240 may be extended andhood 12 may be placed laterally relative to the vessel such thatflap 240 is positioned at least partially along the opening of the pulmonary vein PVLS and only a small portion of the vessel opening is covered such thatblood flow 178 through the vessel may continue unobstructed by thehood 12. In this position,hood 12 is desirably positioned upon the ostium OSLS to allow thehood 12 andablation probe 174 positioned therewithin to treat the underlying tissue while under direct visualization through thehood 12. - As illustrated in
FIGS. 21A to 21C , withextended flap 240 positioned at least partially within the vessel and acting as a guide,hood 12 may be moved circumferentially viacatheter 16, or at least partially, around the ostium OSLS to create one or morediscrete lesions 182 or acontinuous lesion 180.FIG. 21C illustrates the resultinglesion 180 created circumferentially about the ostium OSLS to electrically isolate the tissue region. - In other variations for creating lesions about the ostium of a vessel,
FIG. 22 shows a perspective view of an example of a device utilizing aside port 250 defined along thecatheter 16 proximal to thehood 12 for intravascularly creating lesions around multiple ostia. Although the anchor configuration is illustrated withhelical anchor 170 attached to anchormember 172 extending throughport 250, other anchors which are non-obstructing to the blood flow through the vessel may be utilized, such as basket anchors, mesh anchors, staggered, balloons, etc. An anchor deployed from theside port 250 of thecatheter 16 may providehood 12 additional degrees-of-freedom of controlled motion within the chamber (such as the left atrium LA) of the heart. - In use,
anchor 170 may be deployed throughport 250 proximal to thehood 12 and advanced into, e.g., pulmonary vein PVLS, by advancing anchor member 172 (indicated by the direction of advancement 252) where it may be secured within the vessel without obstructing blood flow therethrough, as shown in the perspective view ofFIG. 23A .Hood 12 may then be articulated via catheter 16 (indicated by the direction of articulation 254) while tethered and guided byanchor member 172 to facilitate the ablation process by allowinghood 12 to be maneuvered especially when isolating two or more ostia, e.g., left superior ostium OSLS and left inferior ostium OSLS, within one continuous circumferential lesion, as shown inFIG. 23B . Other tissue regions may be ablated in the same manner to create lesion patterns around the various ostia or around all four ostia within the left atrium LA. Moreover, the side ported anchor may also provide additional apposition strength for thehood 12 to engage the ablated tissue surface when theanchor 170 is pulled from theside port 250. - Another variation may include having two or more side ports near or at the distal end of the
catheter 16 proximal tohood 12, with each side port deploying a respective anchor. When one anchor secures itself to the right superior/inferior pulmonary vein while the other pulmonary vein anchor secures itself within the left superior/inferior PV, navigation around all four pulmonary vein ostia and apposition to target tissue surface in the vicinity of the four pulmonary vein ostia can be achieved. This can be made so by pulling on each of the two anchor members with varying tension and by rotating thehood 12 about the axis of the anchor members. Both linear lesions connecting the pulmonary veins and circumferential lesions around the respective ostia can be formed by maneuvering thehood 12 accordingly. - The applications of the disclosed invention discussed above are not limited to certain treatments or regions of the body, but may include any number of other treatments and areas of the body. Modification of the above-described methods and devices for carrying out the invention, and variations of aspects of the invention that are obvious to those of skill in the arts are intended to be within the scope of this disclosure. Moreover, various combinations of aspects between examples are also contemplated and are considered to be within the scope of this disclosure as well.
Claims (36)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/959,158 US20080183036A1 (en) | 2006-12-18 | 2007-12-18 | Systems and methods for unobstructed visualization and ablation |
US15/044,667 US10441136B2 (en) | 2006-12-18 | 2016-02-16 | Systems and methods for unobstructed visualization and ablation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87059806P | 2006-12-18 | 2006-12-18 | |
US11/959,158 US20080183036A1 (en) | 2006-12-18 | 2007-12-18 | Systems and methods for unobstructed visualization and ablation |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/044,667 Division US10441136B2 (en) | 2006-12-18 | 2016-02-16 | Systems and methods for unobstructed visualization and ablation |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080183036A1 true US20080183036A1 (en) | 2008-07-31 |
Family
ID=39668755
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/959,158 Abandoned US20080183036A1 (en) | 2006-12-18 | 2007-12-18 | Systems and methods for unobstructed visualization and ablation |
US15/044,667 Active US10441136B2 (en) | 2006-12-18 | 2016-02-16 | Systems and methods for unobstructed visualization and ablation |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/044,667 Active US10441136B2 (en) | 2006-12-18 | 2016-02-16 | Systems and methods for unobstructed visualization and ablation |
Country Status (1)
Country | Link |
---|---|
US (2) | US20080183036A1 (en) |
Cited By (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100191232A1 (en) * | 2009-01-27 | 2010-07-29 | Boveda Marco Medical Llc | Catheters and methods for performing electrophysiological interventions |
US8728011B2 (en) | 2011-07-22 | 2014-05-20 | Michael D. Khoury | Multi wire sheath |
US20140200568A1 (en) * | 2008-10-06 | 2014-07-17 | Virender K. Sharma | Method and Apparatus for Tissue Ablation |
US9014789B2 (en) | 2011-09-22 | 2015-04-21 | The George Washington University | Systems and methods for visualizing ablated tissue |
US20150190616A1 (en) * | 2014-01-07 | 2015-07-09 | Aldo Antonio Salvestro | Medical device including manipulable portion with connected elongate members |
US9084611B2 (en) | 2011-09-22 | 2015-07-21 | The George Washington University | Systems and methods for visualizing ablated tissue |
US20160089172A1 (en) * | 2014-09-30 | 2016-03-31 | Boston Scientific Scimed, Inc. | Devices and methods for applying suction |
US20160256216A1 (en) * | 2013-03-11 | 2016-09-08 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses for pulmonary artery neuromodulation |
US20170119489A1 (en) * | 2014-06-17 | 2017-05-04 | Tau Pnu Medical Co., Ltd. | Tissue protection device for tricuspid regurgitation surgery |
US10058380B2 (en) | 2007-10-05 | 2018-08-28 | Maquet Cordiovascular Llc | Devices and methods for minimally-invasive surgical procedures |
US10064697B2 (en) | 2008-10-06 | 2018-09-04 | Santa Anna Tech Llc | Vapor based ablation system for treating various indications |
US10143517B2 (en) | 2014-11-03 | 2018-12-04 | LuxCath, LLC | Systems and methods for assessment of contact quality |
CN109310283A (en) * | 2016-04-19 | 2019-02-05 | 波士顿科学国际有限公司 | Foley's tube visualization device including reinforcing element |
US10342608B2 (en) | 2012-10-18 | 2019-07-09 | The Board Of Trustees Of The Leland Stanford Junior University | Ablation catheter system and method for deploying same |
US10441136B2 (en) | 2006-12-18 | 2019-10-15 | Intuitive Surgical Operations, Inc. | Systems and methods for unobstructed visualization and ablation |
EP3328293A4 (en) * | 2015-07-31 | 2019-11-27 | University of Utah Research Foundation | Devices, systems, and methods for imaging and treating a selected tissue |
US10695126B2 (en) | 2008-10-06 | 2020-06-30 | Santa Anna Tech Llc | Catheter with a double balloon structure to generate and apply a heated ablative zone to tissue |
US10722301B2 (en) | 2014-11-03 | 2020-07-28 | The George Washington University | Systems and methods for lesion assessment |
US10779904B2 (en) | 2015-07-19 | 2020-09-22 | 460Medical, Inc. | Systems and methods for lesion formation and assessment |
US10842548B2 (en) | 2008-10-06 | 2020-11-24 | Santa Anna Tech Llc | Vapor ablation system with a catheter having more than one positioning element |
US10842557B2 (en) | 2008-10-06 | 2020-11-24 | Santa Anna Tech Llc | Vapor ablation system with a catheter having more than one positioning element and configured to treat duodenal tissue |
US11020175B2 (en) | 2008-10-06 | 2021-06-01 | Santa Anna Tech Llc | Methods of ablating tissue using time-limited treatment periods |
US11096584B2 (en) | 2013-11-14 | 2021-08-24 | The George Washington University | Systems and methods for determining lesion depth using fluorescence imaging |
US11154351B2 (en) * | 2014-11-14 | 2021-10-26 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses for modulation of nerves in communication with the pulmonary system and associated systems and methods |
US11305096B2 (en) | 2014-10-30 | 2022-04-19 | Kardium Inc. | Catheter system |
US11331140B2 (en) | 2016-05-19 | 2022-05-17 | Aqua Heart, Inc. | Heated vapor ablation systems and methods for treating cardiac conditions |
US11457817B2 (en) | 2013-11-20 | 2022-10-04 | The George Washington University | Systems and methods for hyperspectral analysis of cardiac tissue |
US11602270B2 (en) | 2017-02-01 | 2023-03-14 | University Of Utah Research Foundation | Devices and methods for mapping cardiac tissue |
US11723518B2 (en) * | 2017-10-25 | 2023-08-15 | Boston Scientific Scimed, Inc. | Direct visualization catheter and system |
US11806066B2 (en) | 2018-06-01 | 2023-11-07 | Santa Anna Tech Llc | Multi-stage vapor-based ablation treatment methods and vapor generation and delivery systems |
Citations (98)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3559651A (en) * | 1968-10-14 | 1971-02-02 | David H Moss | Body-worn all disposable urinal |
US4569335A (en) * | 1983-04-12 | 1986-02-11 | Sumitomo Electric Industries, Ltd. | Fiberscope |
US4576146A (en) * | 1983-03-22 | 1986-03-18 | Sumitomo Electric Industries, Ltd. | Fiberscope |
US4611594A (en) * | 1984-04-11 | 1986-09-16 | Northwestern University | Medical instrument for containment and removal of calculi |
US4727418A (en) * | 1985-07-02 | 1988-02-23 | Olympus Optical Co., Ltd. | Image processing apparatus |
US4911148A (en) * | 1989-03-14 | 1990-03-27 | Intramed Laboratories, Inc. | Deflectable-end endoscope with detachable flexible shaft assembly |
US4991578A (en) * | 1989-04-04 | 1991-02-12 | Siemens-Pacesetter, Inc. | Method and system for implanting self-anchoring epicardial defibrillation electrodes |
US4994069A (en) * | 1988-11-02 | 1991-02-19 | Target Therapeutics | Vaso-occlusion coil and method |
US4998916A (en) * | 1989-01-09 | 1991-03-12 | Hammerslag Julius G | Steerable medical device |
US4998972A (en) * | 1988-04-28 | 1991-03-12 | Thomas J. Fogarty | Real time angioscopy imaging system |
US5090959A (en) * | 1987-04-30 | 1992-02-25 | Advanced Cardiovascular Systems, Inc. | Imaging balloon dilatation catheter |
US5281238A (en) * | 1991-11-22 | 1994-01-25 | Chin Albert K | Endoscopic ligation instrument |
US5282827A (en) * | 1991-11-08 | 1994-02-01 | Kensey Nash Corporation | Hemostatic puncture closure system and method of use |
US5336252A (en) * | 1992-06-22 | 1994-08-09 | Cohen Donald M | System and method for implanting cardiac electrical leads |
US5385148A (en) * | 1993-07-30 | 1995-01-31 | The Regents Of The University Of California | Cardiac imaging and ablation catheter |
US5391182A (en) * | 1993-08-03 | 1995-02-21 | Origin Medsystems, Inc. | Apparatus and method for closing puncture wounds |
US5496330A (en) * | 1993-02-19 | 1996-03-05 | Boston Scientific Corporation | Surgical extractor with closely angularly spaced individual filaments |
US5498230A (en) * | 1994-10-03 | 1996-03-12 | Adair; Edwin L. | Sterile connector and video camera cover for sterile endoscope |
US5591119A (en) * | 1994-12-07 | 1997-01-07 | Adair; Edwin L. | Sterile surgical coupler and drape |
US5593424A (en) * | 1994-08-10 | 1997-01-14 | Segmed, Inc. | Apparatus and method for reducing and stabilizing the circumference of a vascular structure |
US5593405A (en) * | 1994-07-16 | 1997-01-14 | Osypka; Peter | Fiber optic endoscope |
US5593422A (en) * | 1989-05-29 | 1997-01-14 | Muijs Van De Moer; Wouter M. | Occlusion assembly for sealing openings in blood vessels and a method for sealing openings in blood vessels |
US5709224A (en) * | 1995-06-07 | 1998-01-20 | Radiotherapeutics Corporation | Method and device for permanent vessel occlusion |
US5713907A (en) * | 1995-07-20 | 1998-02-03 | Endotex Interventional Systems, Inc. | Apparatus and method for dilating a lumen and for inserting an intraluminal graft |
US5713946A (en) * | 1993-07-20 | 1998-02-03 | Biosense, Inc. | Apparatus and method for intrabody mapping |
US5716321A (en) * | 1995-10-10 | 1998-02-10 | Conceptus, Inc. | Method for maintaining separation between a falloposcope and a tubal wall |
US5722403A (en) * | 1996-10-28 | 1998-03-03 | Ep Technologies, Inc. | Systems and methods using a porous electrode for ablating and visualizing interior tissue regions |
US5725523A (en) * | 1996-03-29 | 1998-03-10 | Mueller; Richard L. | Lateral-and posterior-aspect method and apparatus for laser-assisted transmyocardial revascularization and other surgical applications |
US5860974A (en) * | 1993-07-01 | 1999-01-19 | Boston Scientific Corporation | Heart ablation catheter with expandable electrode and method of coupling energy to an electrode on a catheter shaft |
US5860991A (en) * | 1992-12-10 | 1999-01-19 | Perclose, Inc. | Method for the percutaneous suturing of a vascular puncture site |
US5865791A (en) * | 1995-06-07 | 1999-02-02 | E.P. Technologies Inc. | Atrial appendage stasis reduction procedure and devices |
US5879366A (en) * | 1996-12-20 | 1999-03-09 | W.L. Gore & Associates, Inc. | Self-expanding defect closure device and method of making and using |
US6012457A (en) * | 1997-07-08 | 2000-01-11 | The Regents Of The University Of California | Device and method for forming a circumferential conduction block in a pulmonary vein |
US6024740A (en) * | 1997-07-08 | 2000-02-15 | The Regents Of The University Of California | Circumferential ablation device assembly |
US6027501A (en) * | 1995-06-23 | 2000-02-22 | Gyrus Medical Limited | Electrosurgical instrument |
US6168591B1 (en) * | 1994-09-09 | 2001-01-02 | Cardiofocus, Inc. | Guide for penetrating phototherapy |
US6168594B1 (en) * | 1992-11-13 | 2001-01-02 | Scimed Life Systems, Inc. | Electrophysiology RF energy treatment device |
US6174307B1 (en) * | 1996-03-29 | 2001-01-16 | Eclipse Surgical Technologies, Inc. | Viewing surgical scope for minimally invasive procedures |
US6178346B1 (en) * | 1998-10-23 | 2001-01-23 | David C. Amundson | Infrared endoscopic imaging in a liquid with suspended particles: method and apparatus |
US6190381B1 (en) * | 1995-06-07 | 2001-02-20 | Arthrocare Corporation | Methods for tissue resection, ablation and aspiration |
US20020004644A1 (en) * | 1999-11-22 | 2002-01-10 | Scimed Life Systems, Inc. | Methods of deploying helical diagnostic and therapeutic element supporting structures within the body |
US20020026145A1 (en) * | 1997-03-06 | 2002-02-28 | Bagaoisan Celso J. | Method and apparatus for emboli containment |
US20030009085A1 (en) * | 2001-06-04 | 2003-01-09 | Olympus Optical Co., Ltd. | Treatment apparatus for endoscope |
US6514249B1 (en) * | 1997-07-08 | 2003-02-04 | Atrionix, Inc. | Positioning system and method for orienting an ablation element within a pulmonary vein ostium |
US6517533B1 (en) * | 1997-07-29 | 2003-02-11 | M. J. Swaminathan | Balloon catheter for controlling tissue remodeling and/or tissue proliferation |
US20030035156A1 (en) * | 2001-08-15 | 2003-02-20 | Sony Corporation | System and method for efficiently performing a white balance operation |
US20030036698A1 (en) * | 2001-08-16 | 2003-02-20 | Robert Kohler | Interventional diagnostic catheter and a method for using a catheter to access artificial cardiac shunts |
US6673090B2 (en) * | 1999-08-04 | 2004-01-06 | Scimed Life Systems, Inc. | Percutaneous catheter and guidewire for filtering during ablation of myocardial or vascular tissue |
US20040006333A1 (en) * | 1994-09-09 | 2004-01-08 | Cardiofocus, Inc. | Coaxial catheter instruments for ablation with radiant energy |
US6676656B2 (en) * | 1994-09-09 | 2004-01-13 | Cardiofocus, Inc. | Surgical ablation with radiant energy |
US6679836B2 (en) * | 2002-06-21 | 2004-01-20 | Scimed Life Systems, Inc. | Universal programmable guide catheter |
US6682526B1 (en) * | 1997-09-11 | 2004-01-27 | Vnus Medical Technologies, Inc. | Expandable catheter having two sets of electrodes, and method of use |
US6689128B2 (en) * | 1996-10-22 | 2004-02-10 | Epicor Medical, Inc. | Methods and devices for ablation |
US6692430B2 (en) * | 2000-04-10 | 2004-02-17 | C2Cure Inc. | Intra vascular imaging apparatus |
US6840923B1 (en) * | 1999-06-24 | 2005-01-11 | Colocare Holdings Pty Limited | Colostomy pump device |
US6840936B2 (en) * | 1996-10-22 | 2005-01-11 | Epicor Medical, Inc. | Methods and devices for ablation |
US20050014995A1 (en) * | 2001-11-09 | 2005-01-20 | David Amundson | Direct, real-time imaging guidance of cardiac catheterization |
US20050015048A1 (en) * | 2003-03-12 | 2005-01-20 | Chiu Jessica G. | Infusion treatment agents, catheters, filter devices, and occlusion devices, and use thereof |
US20050020914A1 (en) * | 2002-11-12 | 2005-01-27 | David Amundson | Coronary sinus access catheter with forward-imaging |
US6849073B2 (en) * | 1998-07-07 | 2005-02-01 | Medtronic, Inc. | Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue |
US20050027163A1 (en) * | 2003-07-29 | 2005-02-03 | Scimed Life Systems, Inc. | Vision catheter |
US6858005B2 (en) * | 2000-04-03 | 2005-02-22 | Neo Guide Systems, Inc. | Tendon-driven endoscope and methods of insertion |
US20050125024A1 (en) * | 2000-06-29 | 2005-06-09 | Concentric Medical, Inc., A Delaware Corporation | Systems, methods and devices for removing obstructions from a blood vessel |
US20050124969A1 (en) * | 2003-03-18 | 2005-06-09 | Fitzgerald Peter J. | Methods and devices for retrieval of a medical agent from a physiological efferent fluid collection site |
US6982740B2 (en) * | 1997-11-24 | 2006-01-03 | Micro-Medical Devices, Inc. | Reduced area imaging devices utilizing selected charge integration periods |
US6984232B2 (en) * | 2003-01-17 | 2006-01-10 | St. Jude Medical, Daig Division, Inc. | Ablation catheter assembly having a virtual electrode comprising portholes |
US20060009737A1 (en) * | 2004-07-12 | 2006-01-12 | Whiting James S | Methods and devices for transseptal access |
US20060009715A1 (en) * | 2000-04-13 | 2006-01-12 | Khairkhahan Alexander K | Method and apparatus for accessing the left atrial appendage |
US20060015096A1 (en) * | 2004-05-28 | 2006-01-19 | Hauck John A | Radio frequency ablation servo catheter and method |
US20060022234A1 (en) * | 1997-10-06 | 2006-02-02 | Adair Edwin L | Reduced area imaging device incorporated within wireless endoscopic devices |
US20060025787A1 (en) * | 2002-06-13 | 2006-02-02 | Guided Delivery Systems, Inc. | Devices and methods for heart valve repair |
US20060025651A1 (en) * | 2004-07-29 | 2006-02-02 | Doron Adler | Endoscope electronics assembly |
US6994094B2 (en) * | 2003-04-29 | 2006-02-07 | Biosense, Inc. | Method and device for transseptal facilitation based on injury patterns |
US20060030844A1 (en) * | 2004-08-04 | 2006-02-09 | Knight Bradley P | Transparent electrode for the radiofrequency ablation of tissue |
US7041098B2 (en) * | 1997-09-11 | 2006-05-09 | Vnus Medical Technologies, Inc. | Expandable vein ligator catheter and method of use |
US7156845B2 (en) * | 1998-07-07 | 2007-01-02 | Medtronic, Inc. | Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue |
US20070005019A1 (en) * | 2005-06-24 | 2007-01-04 | Terumo Kabushiki Kaisha | Catheter assembly |
US7163534B2 (en) * | 2003-10-30 | 2007-01-16 | Medical Cv, Inc. | Laser-based maze procedure for atrial fibrillation |
US20070016130A1 (en) * | 2005-05-06 | 2007-01-18 | Leeflang Stephen A | Complex Shaped Steerable Catheters and Methods for Making and Using Them |
US20070015964A1 (en) * | 2002-05-30 | 2007-01-18 | Eversull Christian S | Apparatus and Methods for Coronary Sinus Access |
US7166537B2 (en) * | 2002-03-18 | 2007-01-23 | Sarcos Investments Lc | Miniaturized imaging device with integrated circuit connector system |
US20070043338A1 (en) * | 2004-03-05 | 2007-02-22 | Hansen Medical, Inc | Robotic catheter system and methods |
US20070043413A1 (en) * | 2005-08-16 | 2007-02-22 | Eversull Christian S | Apparatus and methods for delivering transvenous leads |
US20080009747A1 (en) * | 2005-02-02 | 2008-01-10 | Voyage Medical, Inc. | Transmural subsurface interrogation and ablation |
US20080009859A1 (en) * | 2003-02-13 | 2008-01-10 | Coaptus Medical Corporation | Transseptal left atrial access and septal closure |
US20080015569A1 (en) * | 2005-02-02 | 2008-01-17 | Voyage Medical, Inc. | Methods and apparatus for treatment of atrial fibrillation |
US20080015445A1 (en) * | 2005-02-02 | 2008-01-17 | Voyage Medical, Inc. | Tissue visualization device and method variations |
US20080027464A1 (en) * | 2006-07-26 | 2008-01-31 | Moll Frederic H | Systems and methods for performing minimally invasive surgical operations |
US20080033290A1 (en) * | 2005-10-25 | 2008-02-07 | Voyage Medical, Inc. | Delivery of biological compounds to ischemic and/or infarcted tissue |
US20080033241A1 (en) * | 2006-08-01 | 2008-02-07 | Ruey-Feng Peh | Left atrial appendage closure |
US20090030276A1 (en) * | 2007-07-27 | 2009-01-29 | Voyage Medical, Inc. | Tissue visualization catheter with imaging systems integration |
US20090030412A1 (en) * | 2007-05-11 | 2009-01-29 | Willis N Parker | Visual electrode ablation systems |
US20090054803A1 (en) * | 2005-02-02 | 2009-02-26 | Vahid Saadat | Electrophysiology mapping and visualization system |
US20100004661A1 (en) * | 2006-07-12 | 2010-01-07 | Les Hopitaux Universitaires De Geneve | Medical device for tissue ablation |
US20100004633A1 (en) * | 2008-07-07 | 2010-01-07 | Voyage Medical, Inc. | Catheter control systems |
US20100004506A1 (en) * | 2005-02-02 | 2010-01-07 | Voyage Medical, Inc. | Tissue visualization and manipulation systems |
US20100010311A1 (en) * | 2005-10-25 | 2010-01-14 | Voyage Medical, Inc. | Methods and apparatus for efficient purging |
US20120016221A1 (en) * | 2010-02-12 | 2012-01-19 | Voyage Medical, Inc. | Image stabilization techniques and methods |
Family Cites Families (352)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US623022A (en) | 1899-04-11 | johnson | ||
US2305462A (en) | 1940-06-20 | 1942-12-15 | Wolf Richard | Cystoscopic instrument |
US2453862A (en) | 1947-06-02 | 1948-11-16 | Salisbury Peter Frederic | Gastroscope |
US3874388A (en) | 1973-02-12 | 1975-04-01 | Ochsner Med Found Alton | Shunt defect closure system |
US4175545A (en) | 1977-03-10 | 1979-11-27 | Zafmedico Corp. | Method and apparatus for fiber-optic cardiovascular endoscopy |
US4326529A (en) | 1978-05-26 | 1982-04-27 | The United States Of America As Represented By The United States Department Of Energy | Corneal-shaping electrode |
JPS5869527A (en) | 1981-10-20 | 1983-04-25 | 富士写真フイルム株式会社 | High frequency knife and endoscope using same |
US4470407A (en) | 1982-03-11 | 1984-09-11 | Laserscope, Inc. | Endoscopic device |
US4445892A (en) | 1982-05-06 | 1984-05-01 | Laserscope, Inc. | Dual balloon catheter device |
US5435805A (en) | 1992-08-12 | 1995-07-25 | Vidamed, Inc. | Medical probe device with optical viewing capability |
JPS5993413A (en) | 1982-11-18 | 1984-05-29 | Olympus Optical Co Ltd | Endoscope |
US4681093A (en) * | 1982-12-13 | 1987-07-21 | Sumitomo Electric Industries, Ltd. | Endoscope |
CA1244889A (en) | 1983-01-24 | 1988-11-15 | Kureha Chemical Ind Co Ltd | Device for hyperthermia |
US4619247A (en) | 1983-03-31 | 1986-10-28 | Sumitomo Electric Industries, Ltd. | Catheter |
JPS59181315A (en) | 1983-03-31 | 1984-10-15 | Kiyoshi Inoue | Fiber scope |
JPS60125610U (en) | 1984-02-03 | 1985-08-24 | オリンパス光学工業株式会社 | Strabismus-type rigid endoscope |
EP0214712B1 (en) | 1985-07-31 | 1992-09-02 | C.R. Bard, Inc. | Infrared laser catheter apparatus |
US4917084A (en) | 1985-07-31 | 1990-04-17 | C. R. Bard, Inc. | Infrared laser catheter system |
US4710192A (en) | 1985-12-30 | 1987-12-01 | Liotta Domingo S | Diaphragm and method for occlusion of the descending thoracic aorta |
US4709698A (en) | 1986-05-14 | 1987-12-01 | Thomas J. Fogarty | Heatable dilation catheter |
US4784133A (en) | 1987-01-28 | 1988-11-15 | Mackin Robert A | Working well balloon angioscope and method |
US4961738A (en) | 1987-01-28 | 1990-10-09 | Mackin Robert A | Angioplasty catheter with illumination and visualization within angioplasty balloon |
US4976710A (en) | 1987-01-28 | 1990-12-11 | Mackin Robert A | Working well balloon method |
NL8700329A (en) | 1987-02-11 | 1988-09-01 | Hoed Daniel Stichting | DEVICE AND METHOD FOR EXAMINING AND / OR EXPOSING A CAVE IN A BODY. |
US4943290A (en) | 1987-06-23 | 1990-07-24 | Concept Inc. | Electrolyte purging electrode tip |
IT1235460B (en) | 1987-07-31 | 1992-07-30 | Confida Spa | FLEXIBLE ENDOSCOPE. |
US5372138A (en) | 1988-03-21 | 1994-12-13 | Boston Scientific Corporation | Acousting imaging catheters and the like |
AU3696989A (en) | 1988-05-18 | 1989-12-12 | Kasevich Associates, Inc. | Microwave balloon angioplasty |
US6120437A (en) | 1988-07-22 | 2000-09-19 | Inbae Yoon | Methods for creating spaces at obstructed sites endoscopically and methods therefor |
US4957484A (en) | 1988-07-26 | 1990-09-18 | Automedix Sciences, Inc. | Lymph access catheters and methods of administration |
US5123428A (en) | 1988-10-11 | 1992-06-23 | Schwarz Gerald R | Laparoscopically implanting bladder control apparatus |
US4914521A (en) | 1989-02-03 | 1990-04-03 | Adair Edwin Lloyd | Sterilizable video camera cover |
USRE34002E (en) | 1989-02-03 | 1992-07-21 | Sterilizable video camera cover | |
DE3915636C1 (en) | 1989-05-12 | 1990-04-26 | Sass, Wolfgang, Dr. | |
US4950285A (en) | 1989-11-27 | 1990-08-21 | Wilk Peter J | Suture device |
US5514153A (en) | 1990-03-02 | 1996-05-07 | General Surgical Innovations, Inc. | Method of dissecting tissue layers |
JP2893833B2 (en) | 1990-03-30 | 1999-05-24 | 東レ株式会社 | Endoscopic balloon catheter |
DE69102515T2 (en) | 1990-04-02 | 1994-10-20 | Kanji Inoue | DEVICE FOR CLOSING A SHUTTER OPENING BY MEANS OF A NON-OPERATIONAL METHOD. |
US5236413B1 (en) | 1990-05-07 | 1996-06-18 | Andrew J Feiring | Method and apparatus for inducing the permeation of medication into internal tissue |
US5370647A (en) | 1991-01-23 | 1994-12-06 | Surgical Innovations, Inc. | Tissue and organ extractor |
US5156141A (en) | 1991-03-11 | 1992-10-20 | Helmut Krebs | Connector for coupling an endoscope to a video camera |
JP3065702B2 (en) | 1991-04-23 | 2000-07-17 | オリンパス光学工業株式会社 | Endoscope system |
US5330496A (en) | 1991-05-06 | 1994-07-19 | Alferness Clifton A | Vascular catheter assembly for tissue penetration and for cardiac stimulation and methods thereof |
AU2185192A (en) | 1991-05-29 | 1993-01-08 | Origin Medsystems, Inc. | Retraction apparatus and methods for endoscopic surgery |
US5697281A (en) | 1991-10-09 | 1997-12-16 | Arthrocare Corporation | System and method for electrosurgical cutting and ablation |
JPH05103746A (en) | 1991-10-18 | 1993-04-27 | Olympus Optical Co Ltd | Metabolism information measuring device |
US5697882A (en) | 1992-01-07 | 1997-12-16 | Arthrocare Corporation | System and method for electrosurgical cutting and ablation |
US5334159A (en) | 1992-03-30 | 1994-08-02 | Symbiosis Corporation | Thoracentesis needle assembly utilizing check valve |
FR2689388B1 (en) | 1992-04-07 | 1999-07-16 | Celsa Lg | PERFECTIONALLY RESORBABLE BLOOD FILTER. |
DE4214283A1 (en) | 1992-04-30 | 1993-11-04 | Schneider Co Optische Werke | Contactless length measuring camera - contains semiconducting transducer moved axially within camera body during focussing |
US5672153A (en) | 1992-08-12 | 1997-09-30 | Vidamed, Inc. | Medical probe device and method |
US5527338A (en) | 1992-09-02 | 1996-06-18 | Board Of Regents, The University Of Texas System | Intravascular device |
US5339800A (en) | 1992-09-10 | 1994-08-23 | Devmed Group Inc. | Lens cleaning means for invasive viewing medical instruments with anti-contamination means |
AT397458B (en) | 1992-09-25 | 1994-04-25 | Avl Verbrennungskraft Messtech | SENSOR ARRANGEMENT |
US5313943A (en) | 1992-09-25 | 1994-05-24 | Ep Technologies, Inc. | Catheters and methods for performing cardiac diagnosis and treatment |
US5373840A (en) | 1992-10-02 | 1994-12-20 | Knighton; David R. | Endoscope and method for vein removal |
US5334193A (en) | 1992-11-13 | 1994-08-02 | American Cardiac Ablation Co., Inc. | Fluid cooled ablation catheter |
US6068653A (en) | 1992-11-13 | 2000-05-30 | Scimed Life Systems, Inc. | Electrophysiology catheter device |
US5676693A (en) | 1992-11-13 | 1997-10-14 | Scimed Life Systems, Inc. | Electrophysiology device |
US6923805B1 (en) | 1992-11-13 | 2005-08-02 | Scimed Life Systems, Inc. | Electrophysiology energy treatment devices and methods of use |
US5348554A (en) | 1992-12-01 | 1994-09-20 | Cardiac Pathways Corporation | Catheter for RF ablation with cooled electrode |
US5403326A (en) | 1993-02-01 | 1995-04-04 | The Regents Of The University Of California | Method for performing a gastric wrap of the esophagus for use in the treatment of esophageal reflux |
US6161543A (en) | 1993-02-22 | 2000-12-19 | Epicor, Inc. | Methods of epicardial ablation for creating a lesion around the pulmonary veins |
US5797960A (en) | 1993-02-22 | 1998-08-25 | Stevens; John H. | Method and apparatus for thoracoscopic intracardiac procedures |
US6346074B1 (en) | 1993-02-22 | 2002-02-12 | Heartport, Inc. | Devices for less invasive intracardiac interventions |
US5306234A (en) | 1993-03-23 | 1994-04-26 | Johnson W Dudley | Method for closing an atrial appendage |
US5571088A (en) | 1993-07-01 | 1996-11-05 | Boston Scientific Corporation | Ablation catheters |
DE69432148T2 (en) | 1993-07-01 | 2003-10-16 | Boston Scient Ltd | CATHETER FOR IMAGE DISPLAY, DISPLAY OF ELECTRICAL SIGNALS AND ABLATION |
US6285898B1 (en) | 1993-07-20 | 2001-09-04 | Biosense, Inc. | Cardiac electromechanics |
WO1995003843A1 (en) | 1993-07-30 | 1995-02-09 | The Regents Of The University Of California | Endocardial infusion catheter |
US5575756A (en) | 1993-08-16 | 1996-11-19 | Olympus Optical Co., Ltd. | Endoscope apparatus |
US5431649A (en) | 1993-08-27 | 1995-07-11 | Medtronic, Inc. | Method and apparatus for R-F ablation |
US5405376A (en) | 1993-08-27 | 1995-04-11 | Medtronic, Inc. | Method and apparatus for ablation |
US6129724A (en) | 1993-10-14 | 2000-10-10 | Ep Technologies, Inc. | Systems and methods for forming elongated lesion patterns in body tissue using straight or curvilinear electrode elements |
US5797903A (en) | 1996-04-12 | 1998-08-25 | Ep Technologies, Inc. | Tissue heating and ablation systems and methods using porous electrode structures with electrically conductive surfaces |
US5575810A (en) | 1993-10-15 | 1996-11-19 | Ep Technologies, Inc. | Composite structures and methods for ablating tissue to form complex lesion patterns in the treatment of cardiac conditions and the like |
US5462521A (en) | 1993-12-21 | 1995-10-31 | Angeion Corporation | Fluid cooled and perfused tip for a catheter |
US5471515A (en) | 1994-01-28 | 1995-11-28 | California Institute Of Technology | Active pixel sensor with intra-pixel charge transfer |
US5746747A (en) | 1994-05-13 | 1998-05-05 | Mckeating; John A. | Polypectomy instrument |
US5842973A (en) | 1994-05-17 | 1998-12-01 | Bullard; James Roger | Nasal intubation apparatus |
US5575788A (en) | 1994-06-24 | 1996-11-19 | Stuart D. Edwards | Thin layer ablation apparatus |
US5681308A (en) | 1994-06-24 | 1997-10-28 | Stuart D. Edwards | Ablation apparatus for cardiac chambers |
US6056744A (en) | 1994-06-24 | 2000-05-02 | Conway Stuart Medical, Inc. | Sphincter treatment apparatus |
US5505730A (en) | 1994-06-24 | 1996-04-09 | Stuart D. Edwards | Thin layer ablation apparatus |
JP2802244B2 (en) | 1994-08-29 | 1998-09-24 | オリンパス光学工業株式会社 | Endoscope sheath |
US6572609B1 (en) | 1999-07-14 | 2003-06-03 | Cardiofocus, Inc. | Phototherapeutic waveguide apparatus |
US6270492B1 (en) | 1994-09-09 | 2001-08-07 | Cardiofocus, Inc. | Phototherapeutic apparatus with diffusive tip assembly |
US6423055B1 (en) | 1999-07-14 | 2002-07-23 | Cardiofocus, Inc. | Phototherapeutic wave guide apparatus |
US6102905A (en) | 1994-09-09 | 2000-08-15 | Cardiofocus, Inc. | Phototherapy device including housing for an optical element and method of making |
US6558375B1 (en) | 2000-07-14 | 2003-05-06 | Cardiofocus, Inc. | Cardiac ablation instrument |
US6579285B2 (en) | 1994-09-09 | 2003-06-17 | Cardiofocus, Inc. | Photoablation with infrared radiation |
US5792045A (en) | 1994-10-03 | 1998-08-11 | Adair; Edwin L. | Sterile surgical coupler and drape |
WO1996022111A1 (en) | 1995-01-19 | 1996-07-25 | Sound Science Limited Partnership | Local delivery and monitoring of drugs |
US6690963B2 (en) | 1995-01-24 | 2004-02-10 | Biosense, Inc. | System for determining the location and orientation of an invasive medical instrument |
US5897553A (en) | 1995-11-02 | 1999-04-27 | Medtronic, Inc. | Ball point fluid-assisted electrocautery device |
US6063081A (en) | 1995-02-22 | 2000-05-16 | Medtronic, Inc. | Fluid-assisted electrocautery device |
US5515853A (en) | 1995-03-28 | 1996-05-14 | Sonometrics Corporation | Three-dimensional digital ultrasound tracking system |
JP3134726B2 (en) | 1995-08-14 | 2001-02-13 | 富士写真光機株式会社 | Ultrasound diagnostic equipment |
JP3151153B2 (en) | 1995-09-20 | 2001-04-03 | 定夫 尾股 | Frequency deviation detection circuit and measuring instrument using the same |
US6726677B1 (en) | 1995-10-13 | 2004-04-27 | Transvascular, Inc. | Stabilized tissue penetrating catheters |
AU690862B2 (en) | 1995-12-04 | 1998-04-30 | Target Therapeutics, Inc. | Fibered micro vaso-occlusive devices |
US5925038A (en) | 1996-01-19 | 1999-07-20 | Ep Technologies, Inc. | Expandable-collapsible electrode structures for capacitive coupling to tissue |
US5895417A (en) | 1996-03-06 | 1999-04-20 | Cardiac Pathways Corporation | Deflectable loop design for a linear lesion ablation apparatus |
US6063077A (en) | 1996-04-08 | 2000-05-16 | Cardima, Inc. | Linear ablation device and assembly |
US6270477B1 (en) | 1996-05-20 | 2001-08-07 | Percusurge, Inc. | Catheter for emboli containment |
US5754313A (en) | 1996-07-17 | 1998-05-19 | Welch Allyn, Inc. | Imager assembly |
US6830577B2 (en) | 1996-07-26 | 2004-12-14 | Kensey Nash Corporation | System and method of use for treating occluded vessels and diseased tissue |
US6905505B2 (en) | 1996-07-26 | 2005-06-14 | Kensey Nash Corporation | System and method of use for agent delivery and revascularizing of grafts and vessels |
US5826576A (en) | 1996-08-08 | 1998-10-27 | Medtronic, Inc. | Electrophysiology catheter with multifunction wire and method for making |
US6126682A (en) | 1996-08-13 | 2000-10-03 | Oratec Interventions, Inc. | Method for treating annular fissures in intervertebral discs |
US6464697B1 (en) | 1998-02-19 | 2002-10-15 | Curon Medical, Inc. | Stomach and adjoining tissue regions in the esophagus |
US6311692B1 (en) | 1996-10-22 | 2001-11-06 | Epicor, Inc. | Apparatus and method for diagnosis and therapy of electrophysiological disease |
US6237605B1 (en) | 1996-10-22 | 2001-05-29 | Epicor, Inc. | Methods of epicardial ablation |
US7052493B2 (en) | 1996-10-22 | 2006-05-30 | Epicor Medical, Inc. | Methods and devices for ablation |
US6805128B1 (en) | 1996-10-22 | 2004-10-19 | Epicor Medical, Inc. | Apparatus and method for ablating tissue |
US5848969A (en) | 1996-10-28 | 1998-12-15 | Ep Technologies, Inc. | Systems and methods for visualizing interior tissue regions using expandable imaging structures |
US5908445A (en) | 1996-10-28 | 1999-06-01 | Ep Technologies, Inc. | Systems for visualizing interior tissue regions including an actuator to move imaging element |
US5752518A (en) | 1996-10-28 | 1998-05-19 | Ep Technologies, Inc. | Systems and methods for visualizing interior regions of the body |
US5904651A (en) | 1996-10-28 | 1999-05-18 | Ep Technologies, Inc. | Systems and methods for visualizing tissue during diagnostic or therapeutic procedures |
US5827268A (en) | 1996-10-30 | 1998-10-27 | Hearten Medical, Inc. | Device for the treatment of patent ductus arteriosus and method of using the device |
US5749890A (en) | 1996-12-03 | 1998-05-12 | Shaknovich; Alexander | Method and system for stent placement in ostial lesions |
US6071279A (en) | 1996-12-19 | 2000-06-06 | Ep Technologies, Inc. | Branched structures for supporting multiple electrode elements |
JP3134287B2 (en) | 1997-01-30 | 2001-02-13 | 株式会社ニッショー | Catheter assembly for endocardial suture surgery |
US5968053A (en) | 1997-01-31 | 1999-10-19 | Cardiac Assist Technologies, Inc. | Method and apparatus for implanting a graft in a vessel of a patient |
US6295989B1 (en) | 1997-02-06 | 2001-10-02 | Arteria Medical Science, Inc. | ICA angioplasty with cerebral protection |
US6086534A (en) | 1997-03-07 | 2000-07-11 | Cardiogenesis Corporation | Apparatus and method of myocardial revascularization using ultrasonic pulse-echo distance ranging |
AU6673498A (en) | 1997-03-10 | 1998-09-29 | Robin Medical Inc. | Method and apparatus for the assessment and display of variability in mechanicalactivity of the heart, and enhancement of ultrasound contrast imaging by variab ility analysis |
US6086582A (en) | 1997-03-13 | 2000-07-11 | Altman; Peter A. | Cardiac drug delivery system |
US5944690A (en) | 1997-03-17 | 1999-08-31 | C.R. Bard, Inc. | Slidable control mechanism for steerable catheter |
US5897487A (en) | 1997-04-15 | 1999-04-27 | Asahi Kogaku Kogyo Kabushiki Kaisha | Front end hood for endoscope |
US6081740A (en) | 1997-04-23 | 2000-06-27 | Accumed International, Inc. | Method and apparatus for imaging and sampling diseased tissue |
US5971983A (en) | 1997-05-09 | 1999-10-26 | The Regents Of The University Of California | Tissue ablation device and method of use |
US5941845A (en) | 1997-08-05 | 1999-08-24 | Irvine Biomedical, Inc. | Catheter having multiple-needle electrode and methods thereof |
US6251109B1 (en) | 1997-06-27 | 2001-06-26 | Daig Corporation | Process and device for the treatment of atrial arrhythmia |
US6500174B1 (en) | 1997-07-08 | 2002-12-31 | Atrionix, Inc. | Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member |
US6164283A (en) | 1997-07-08 | 2000-12-26 | The Regents Of The University Of California | Device and method for forming a circumferential conduction block in a pulmonary vein |
US6997925B2 (en) | 1997-07-08 | 2006-02-14 | Atrionx, Inc. | Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall |
EP0893137B1 (en) | 1997-07-22 | 2004-03-31 | Terumo Kabushiki Kaisha | Assembly for an indwelling catheter and method of making it |
US6459919B1 (en) | 1997-08-26 | 2002-10-01 | Color Kinetics, Incorporated | Precision illumination methods and systems |
US6015414A (en) | 1997-08-29 | 2000-01-18 | Stereotaxis, Inc. | Method and apparatus for magnetically controlling motion direction of a mechanically pushed catheter |
US6043839A (en) | 1997-10-06 | 2000-03-28 | Adair; Edwin L. | Reduced area imaging devices |
US5929901A (en) | 1997-10-06 | 1999-07-27 | Adair; Edwin L. | Reduced area imaging devices incorporated within surgical instruments |
US6086528A (en) | 1997-09-11 | 2000-07-11 | Adair; Edwin L. | Surgical devices with removable imaging capability and methods of employing same |
US6211904B1 (en) | 1997-09-11 | 2001-04-03 | Edwin L. Adair | Surgical devices incorporating reduced area imaging devices |
US6310642B1 (en) | 1997-11-24 | 2001-10-30 | Micro-Medical Devices, Inc. | Reduced area imaging devices incorporated within surgical instruments |
US5986693A (en) | 1997-10-06 | 1999-11-16 | Adair; Edwin L. | Reduced area imaging devices incorporated within surgical instruments |
US6240312B1 (en) | 1997-10-23 | 2001-05-29 | Robert R. Alfano | Remote-controllable, micro-scale device for use in in vivo medical diagnosis and/or treatment |
US5997571A (en) | 1997-12-17 | 1999-12-07 | Cardiofocus, Inc. | Non-occluding phototherapy probe stabilizers |
US6071302A (en) | 1997-12-31 | 2000-06-06 | Cardiofocus, Inc. | Phototherapeutic apparatus for wide-angle diffusion |
US6423058B1 (en) | 1998-02-19 | 2002-07-23 | Curon Medical, Inc. | Assemblies to visualize and treat sphincters and adjoining tissue regions |
US7214230B2 (en) | 1998-02-24 | 2007-05-08 | Hansen Medical, Inc. | Flexible instrument |
US7090683B2 (en) | 1998-02-24 | 2006-08-15 | Hansen Medical, Inc. | Flexible instrument |
US6142993A (en) | 1998-02-27 | 2000-11-07 | Ep Technologies, Inc. | Collapsible spline structure using a balloon as an expanding actuator |
US5997509A (en) | 1998-03-06 | 1999-12-07 | Cornell Research Foundation, Inc. | Minimally invasive gene therapy delivery device and method |
US6115626A (en) | 1998-03-26 | 2000-09-05 | Scimed Life Systems, Inc. | Systems and methods using annotated images for controlling the use of diagnostic or therapeutic instruments in instruments in interior body regions |
JPH11299725A (en) | 1998-04-21 | 1999-11-02 | Olympus Optical Co Ltd | Hood for endoscope |
US6522930B1 (en) | 1998-05-06 | 2003-02-18 | Atrionix, Inc. | Irrigated ablation device assembly |
CA2332107A1 (en) | 1998-05-13 | 1999-11-18 | Inbae Yoon | Penetrating endoscope and endoscopic surgical instrument with cmos image sensor and display |
US7263397B2 (en) | 1998-06-30 | 2007-08-28 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Method and apparatus for catheter navigation and location and mapping in the heart |
US6494902B2 (en) | 1998-07-07 | 2002-12-17 | Medtronic, Inc. | Method for creating a virtual electrode for the ablation of tissue and for selected protection of tissue during an ablation |
US6238393B1 (en) | 1998-07-07 | 2001-05-29 | Medtronic, Inc. | Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue |
US6315777B1 (en) | 1998-07-07 | 2001-11-13 | Medtronic, Inc. | Method and apparatus for creating a virtual electrode used for the ablation of tissue |
US6537272B2 (en) | 1998-07-07 | 2003-03-25 | Medtronic, Inc. | Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue |
US6290689B1 (en) | 1999-10-22 | 2001-09-18 | Corazón Technologies, Inc. | Catheter devices and methods for their use in the treatment of calcified vascular occlusions |
US6394096B1 (en) | 1998-07-15 | 2002-05-28 | Corazon Technologies, Inc. | Method and apparatus for treatment of cardiovascular tissue mineralization |
US6527979B2 (en) | 1999-08-27 | 2003-03-04 | Corazon Technologies, Inc. | Catheter systems and methods for their use in the treatment of calcified vascular occlusions |
US6562020B1 (en) | 1998-07-15 | 2003-05-13 | Corazon Technologies, Inc. | Kits for use in the treatment of vascular calcified lesions |
CA2337113C (en) | 1998-07-15 | 2009-06-23 | Corazon Technologies, Inc. | Methods and devices for reducing the mineral content of vascular calcified lesions |
US6112123A (en) | 1998-07-28 | 2000-08-29 | Endonetics, Inc. | Device and method for ablation of tissue |
US6593884B1 (en) | 1998-08-02 | 2003-07-15 | Super Dimension Ltd. | Intrabody navigation system for medical applications |
US6139508A (en) | 1998-08-04 | 2000-10-31 | Endonetics, Inc. | Articulated medical device |
US6099498A (en) | 1998-09-02 | 2000-08-08 | Embol-X, Inc | Cardioplegia access view probe and methods of use |
US6123703A (en) | 1998-09-19 | 2000-09-26 | Tu; Lily Chen | Ablation catheter and methods for treating tissues |
US6123718A (en) | 1998-11-02 | 2000-09-26 | Polymerex Medical Corp. | Balloon catheter |
US6152144A (en) | 1998-11-06 | 2000-11-28 | Appriva Medical, Inc. | Method and device for left atrial appendage occlusion |
US6162179A (en) | 1998-12-08 | 2000-12-19 | Scimed Life Systems, Inc. | Loop imaging catheter |
US6896690B1 (en) | 2000-01-27 | 2005-05-24 | Viacor, Inc. | Cardiac valve procedure methods and devices |
US6396873B1 (en) | 1999-02-25 | 2002-05-28 | Envision Advanced Medical Systems | Optical device |
US6325797B1 (en) | 1999-04-05 | 2001-12-04 | Medtronic, Inc. | Ablation catheter and method for isolating a pulmonary vein |
US6167297A (en) | 1999-05-05 | 2000-12-26 | Benaron; David A. | Detecting, localizing, and targeting internal sites in vivo using optical contrast agents |
JP3490933B2 (en) | 1999-06-07 | 2004-01-26 | ペンタックス株式会社 | Swallowable endoscope device |
US6306132B1 (en) | 1999-06-17 | 2001-10-23 | Vivant Medical | Modular biopsy and microwave ablation needle delivery apparatus adapted to in situ assembly and method of use |
US8540704B2 (en) | 1999-07-14 | 2013-09-24 | Cardiofocus, Inc. | Guided cardiac ablation catheters |
US20050234437A1 (en) | 1999-07-14 | 2005-10-20 | Cardiofocus, Inc. | Deflectable sheath catheters with out-of-plane bent tip |
US20050234436A1 (en) | 1999-07-14 | 2005-10-20 | Cardiofocus, Inc. | Methods of cardiac ablation in the vicinity of the right inferior pulmonary vein |
US7935108B2 (en) | 1999-07-14 | 2011-05-03 | Cardiofocus, Inc. | Deflectable sheath catheters |
US20050222558A1 (en) | 1999-07-14 | 2005-10-06 | Cardiofocus, Inc. | Methods of cardiac ablation employing a deflectable sheath catheter |
EP1207788A4 (en) | 1999-07-19 | 2009-12-09 | St Jude Medical Atrial Fibrill | Apparatus and method for ablating tissue |
US20040167503A1 (en) | 1999-08-25 | 2004-08-26 | Cardiofocus, Inc. | Malleable surgical ablation instruments |
US6755811B1 (en) | 1999-08-25 | 2004-06-29 | Corazon Technologies, Inc. | Methods and devices for reducing the mineral content of a region of non-intimal vascular tissue |
US20040147911A1 (en) | 1999-08-25 | 2004-07-29 | Cardiofocus, Inc. | Surgical ablation instruments for forming an encircling lesion |
US6702780B1 (en) | 1999-09-08 | 2004-03-09 | Super Dimension Ltd. | Steering configuration for catheter with rigid distal device |
US6458151B1 (en) | 1999-09-10 | 2002-10-01 | Frank S. Saltiel | Ostial stent positioning device and method |
US6315778B1 (en) | 1999-09-10 | 2001-11-13 | C. R. Bard, Inc. | Apparatus for creating a continuous annular lesion |
US6423051B1 (en) | 1999-09-16 | 2002-07-23 | Aaron V. Kaplan | Methods and apparatus for pericardial access |
US6231561B1 (en) | 1999-09-20 | 2001-05-15 | Appriva Medical, Inc. | Method and apparatus for closing a body lumen |
US6385476B1 (en) | 1999-09-21 | 2002-05-07 | Biosense, Inc. | Method and apparatus for intracardially surveying a condition of a chamber of a heart |
US6915154B1 (en) | 1999-09-24 | 2005-07-05 | National Research Council Of Canada | Method and apparatus for performing intra-operative angiography |
US6485489B2 (en) | 1999-10-02 | 2002-11-26 | Quantum Cor, Inc. | Catheter system for repairing a mitral valve annulus |
US7019610B2 (en) | 2002-01-23 | 2006-03-28 | Stereotaxis, Inc. | Magnetic navigation system |
US6533767B2 (en) | 2000-03-20 | 2003-03-18 | Corazon Technologies, Inc. | Methods for enhancing fluid flow through an obstructed vascular site, and systems and kits for use in practicing the same |
US6488671B1 (en) | 1999-10-22 | 2002-12-03 | Corazon Technologies, Inc. | Methods for enhancing fluid flow through an obstructed vascular site, and systems and kits for use in practicing the same |
US6780151B2 (en) | 1999-10-26 | 2004-08-24 | Acmi Corporation | Flexible ureteropyeloscope |
US6613062B1 (en) | 1999-10-29 | 2003-09-02 | Medtronic, Inc. | Method and apparatus for providing intra-pericardial access |
US7758521B2 (en) | 1999-10-29 | 2010-07-20 | Medtronic, Inc. | Methods and systems for accessing the pericardial space |
US6529756B1 (en) | 1999-11-22 | 2003-03-04 | Scimed Life Systems, Inc. | Apparatus for mapping and coagulating soft tissue in or around body orifices |
US6626855B1 (en) | 1999-11-26 | 2003-09-30 | Therus Corpoation | Controlled high efficiency lesion formation using high intensity ultrasound |
US6156350A (en) | 1999-12-02 | 2000-12-05 | Corazon Technologies, Inc. | Methods and kits for use in preventing restenosis |
WO2001053871A2 (en) | 2000-01-21 | 2001-07-26 | Molecular Diagnostics, Inc. | In-vivo tissue inspection and sampling |
US6892091B1 (en) | 2000-02-18 | 2005-05-10 | Biosense, Inc. | Catheter, method and apparatus for generating an electrical map of a chamber of the heart |
US6478769B1 (en) | 2000-02-22 | 2002-11-12 | The Board Of Trustees Of The University Of Arkansas | Anatomical fluid evacuation apparatus and method |
US6544195B2 (en) | 2000-03-04 | 2003-04-08 | Joseph F. Wilson | Tissue of foreign body extractor |
JP2001258822A (en) | 2000-03-14 | 2001-09-25 | Olympus Optical Co Ltd | Endoscope |
US6440061B1 (en) | 2000-03-24 | 2002-08-27 | Donald E. Wenner | Laparoscopic instrument system for real-time biliary exploration and stone removal |
IL135571A0 (en) | 2000-04-10 | 2001-05-20 | Doron Adler | Minimal invasive surgery imaging system |
US6650923B1 (en) | 2000-04-13 | 2003-11-18 | Ev3 Sunnyvale, Inc. | Method for accessing the left atrium of the heart by locating the fossa ovalis |
US6558382B2 (en) | 2000-04-27 | 2003-05-06 | Medtronic, Inc. | Suction stabilized epicardial ablation devices |
US6375654B1 (en) | 2000-05-19 | 2002-04-23 | Cardiofocus, Inc. | Catheter system with working portion radially expandable upon rotation |
US6532380B1 (en) | 2000-06-30 | 2003-03-11 | Cedars Sinai Medical Center | Image guidance for coronary stent deployment |
US6811562B1 (en) | 2000-07-31 | 2004-11-02 | Epicor, Inc. | Procedures for photodynamic cardiac ablation therapy and devices for those procedures |
US7399271B2 (en) | 2004-01-09 | 2008-07-15 | Cardiokinetix, Inc. | Ventricular partitioning device |
JP2002058642A (en) | 2000-08-21 | 2002-02-26 | Asahi Optical Co Ltd | Imaging element for electronic endoscope |
US6605055B1 (en) | 2000-09-13 | 2003-08-12 | Cardiofocus, Inc. | Balloon catheter with irrigation sheath |
JP2002177198A (en) | 2000-10-02 | 2002-06-25 | Olympus Optical Co Ltd | Endoscope |
US6540733B2 (en) | 2000-12-29 | 2003-04-01 | Corazon Technologies, Inc. | Proton generating catheters and methods for their use in enhancing fluid flow through a vascular site occupied by a calcified vascular occlusion |
DE10115341A1 (en) | 2001-03-28 | 2002-10-02 | Philips Corp Intellectual Pty | Method and imaging ultrasound system for determining the position of a catheter |
US7422579B2 (en) | 2001-05-01 | 2008-09-09 | St. Jude Medical Cardiology Divison, Inc. | Emboli protection devices and related methods of use |
US7160296B2 (en) | 2001-05-10 | 2007-01-09 | Rita Medical Systems, Inc. | Tissue ablation apparatus and method |
US6635070B2 (en) | 2001-05-21 | 2003-10-21 | Bacchus Vascular, Inc. | Apparatus and methods for capturing particulate material within blood vessels |
US6771996B2 (en) | 2001-05-24 | 2004-08-03 | Cardiac Pacemakers, Inc. | Ablation and high-resolution mapping catheter system for pulmonary vein foci elimination |
US6773402B2 (en) | 2001-07-10 | 2004-08-10 | Biosense, Inc. | Location sensing with real-time ultrasound imaging |
US7125421B2 (en) | 2001-08-31 | 2006-10-24 | Mitral Interventions, Inc. | Method and apparatus for valve repair |
AU2002325761A1 (en) | 2001-09-28 | 2003-04-14 | Institut De Cardiologie De Montreal | Method for identification and visualization of atrial tissue |
WO2003033050A1 (en) | 2001-10-12 | 2003-04-24 | Applied Medical Resources Corporation | High-flow low-pressure irrigation system |
WO2003041603A1 (en) | 2001-11-14 | 2003-05-22 | Latis, Inc. | Improved catheters for clot removal |
US7588535B2 (en) | 2001-12-11 | 2009-09-15 | C2Cure Inc. | Apparatus, method and system for intravascular photographic imaging |
JP4430939B2 (en) | 2001-12-26 | 2010-03-10 | イエール ユニバーシティ | Blood vessel |
US7717899B2 (en) | 2002-01-28 | 2010-05-18 | Cardiac Pacemakers, Inc. | Inner and outer telescoping catheter delivery system |
JP3826045B2 (en) | 2002-02-07 | 2006-09-27 | オリンパス株式会社 | Endoscope hood |
US6974464B2 (en) | 2002-02-28 | 2005-12-13 | 3F Therapeutics, Inc. | Supportless atrioventricular heart valve and minimally invasive delivery systems thereof |
US6712798B2 (en) | 2002-03-18 | 2004-03-30 | Corazon Technologies, Inc. | Multilumen catheters and methods for their use |
US20060146172A1 (en) | 2002-03-18 | 2006-07-06 | Jacobsen Stephen C | Miniaturized utility device having integrated optical capabilities |
US7787939B2 (en) | 2002-03-18 | 2010-08-31 | Sterling Lc | Miniaturized imaging device including utility aperture and SSID |
US6866651B2 (en) | 2002-03-20 | 2005-03-15 | Corazon Technologies, Inc. | Methods and devices for the in situ dissolution of renal calculi |
US6932809B2 (en) | 2002-05-14 | 2005-08-23 | Cardiofocus, Inc. | Safety shut-off device for laser surgical instruments employing blackbody emitters |
US7118566B2 (en) | 2002-05-16 | 2006-10-10 | Medtronic, Inc. | Device and method for needle-less interstitial injection of fluid for ablation of cardiac tissue |
JP2005525896A (en) | 2002-05-16 | 2005-09-02 | シー2キュア インコーポレイティド | Small camera head |
US8956280B2 (en) | 2002-05-30 | 2015-02-17 | Intuitive Surgical Operations, Inc. | Apparatus and methods for placing leads using direct visualization |
US7101395B2 (en) | 2002-06-12 | 2006-09-05 | Mitral Interventions, Inc. | Method and apparatus for tissue connection |
US6783491B2 (en) | 2002-06-13 | 2004-08-31 | Vahid Saadat | Shape lockable apparatus and method for advancing an instrument through unsupported anatomy |
US7421295B2 (en) | 2002-07-19 | 2008-09-02 | Oscor Inc. | Implantable cardiac lead having removable fluid delivery port |
US6887237B2 (en) | 2002-07-22 | 2005-05-03 | Medtronic, Inc. | Method for treating tissue with a wet electrode and apparatus for using same |
US6701581B2 (en) | 2002-08-10 | 2004-03-09 | Epicor Industries, Inc. | Clamp retention device |
US6863668B2 (en) | 2002-08-16 | 2005-03-08 | Edwards Lifesciences Corporation | Articulation mechanism for medical devices |
JP4511935B2 (en) | 2002-08-24 | 2010-07-28 | サブラマニアム シー. クリシュナン | Transseptal puncture device |
US6755790B2 (en) | 2002-10-14 | 2004-06-29 | Medtronic, Inc. | Transseptal access tissue thickness sensing dilator devices and methods for fabricating and using same |
WO2004041183A2 (en) | 2002-11-01 | 2004-05-21 | The Regents Of The University Of California | Methods of treating pulmonary fibrotic disorders |
US6899672B2 (en) | 2002-11-08 | 2005-05-31 | Scimed Life Systems, Inc. | Endoscopic imaging system including removable deflection device |
AU2002952663A0 (en) | 2002-11-14 | 2002-11-28 | Western Sydney Area Health Service | An intramural needle-tipped surgical device |
US20040158289A1 (en) | 2002-11-30 | 2004-08-12 | Girouard Steven D. | Method and apparatus for cell and electrical therapy of living tissue |
US20040138707A1 (en) | 2003-01-14 | 2004-07-15 | Greenhalgh E. Skott | Anchor removable from a substrate |
US20040249367A1 (en) | 2003-01-15 | 2004-12-09 | Usgi Medical Corp. | Endoluminal tool deployment system |
AU2004216229B2 (en) | 2003-02-21 | 2010-12-09 | Electro-Cat, Llc | System and method for measuring cross-sectional areas and pressure gradients in luminal organs |
WO2004078066A2 (en) * | 2003-03-03 | 2004-09-16 | Sinus Rhythm Technologies, Inc. | Primary examiner |
US7658747B2 (en) | 2003-03-12 | 2010-02-09 | Nmt Medical, Inc. | Medical device for manipulation of a medical implant |
US20070055142A1 (en) | 2003-03-14 | 2007-03-08 | Webler William E | Method and apparatus for image guided position tracking during percutaneous procedures |
KR20060034627A (en) | 2003-03-18 | 2006-04-24 | 캐사로스 메디컬 시스템, 인코포레이티드 | Methods and devices for retrieval of a medical agent from a physiological efferent fluid collection site |
US7293562B2 (en) | 2003-03-27 | 2007-11-13 | Cierra, Inc. | Energy based devices and methods for treatment of anatomic tissue defects |
US6939348B2 (en) | 2003-03-27 | 2005-09-06 | Cierra, Inc. | Energy based devices and methods for treatment of patent foramen ovale |
US20040199052A1 (en) | 2003-04-01 | 2004-10-07 | Scimed Life Systems, Inc. | Endoscopic imaging system |
US20040215180A1 (en) | 2003-04-25 | 2004-10-28 | Medtronic, Inc. | Ablation of stomach lining to treat obesity |
US20040220471A1 (en) | 2003-04-29 | 2004-11-04 | Yitzhack Schwartz | Method and device for transseptal facilitation using location system |
JP4414682B2 (en) | 2003-06-06 | 2010-02-10 | オリンパス株式会社 | Ultrasound endoscope device |
US20040260182A1 (en) | 2003-06-23 | 2004-12-23 | Zuluaga Andres F. | Intraluminal spectroscope with wall contacting probe |
JP4599353B2 (en) | 2003-07-17 | 2010-12-15 | コラゾン テクノロジーズ インコーポレーティッド | Device for percutaneously treating aortic stenosis |
US7534204B2 (en) | 2003-09-03 | 2009-05-19 | Guided Delivery Systems, Inc. | Cardiac visualization devices and methods |
US7569052B2 (en) | 2003-09-12 | 2009-08-04 | Boston Scientific Scimed, Inc. | Ablation catheter with tissue protecting assembly |
US20050059862A1 (en) | 2003-09-12 | 2005-03-17 | Scimed Life Systems, Inc. | Cannula with integrated imaging and optical capability |
US7736362B2 (en) | 2003-09-15 | 2010-06-15 | Boston Scientific Scimed, Inc. | Catheter balloons |
US8172747B2 (en) | 2003-09-25 | 2012-05-08 | Hansen Medical, Inc. | Balloon visualization for traversing a tissue wall |
US7435248B2 (en) | 2003-09-26 | 2008-10-14 | Boston Scientific Scimed, Inc. | Medical probes for creating and diagnosing circumferential lesions within or around the ostium of a vessel |
US7207989B2 (en) | 2003-10-27 | 2007-04-24 | Biosense Webster, Inc. | Method for ablating with needle electrode |
JP4496223B2 (en) | 2003-11-06 | 2010-07-07 | エヌエムティー メディカル, インコーポレイティッド | Septal penetration device |
US20050215895A1 (en) | 2003-11-12 | 2005-09-29 | Popp Richard L | Devices and methods for obtaining three-dimensional images of an internal body site |
EP3345577A1 (en) | 2003-12-04 | 2018-07-11 | Boston Scientific Scimed, Inc. | System for delivering a left atrail appendange containment device |
WO2005062823A2 (en) | 2003-12-19 | 2005-07-14 | Savacor, Inc. | Digital electrode for cardiac rhythm management |
JP3823321B2 (en) | 2003-12-25 | 2006-09-20 | 有限会社エスアールジェイ | Balloon control device |
WO2005077435A1 (en) | 2004-01-19 | 2005-08-25 | Atul Kumar | A system for distending body tissue cavities by continuous flow irrigation |
US20050228452A1 (en) | 2004-02-11 | 2005-10-13 | Mourlas Nicholas J | Steerable catheters and methods for using them |
US7186214B2 (en) | 2004-02-12 | 2007-03-06 | Medtronic, Inc. | Instruments and methods for accessing an anatomic space |
US20050197623A1 (en) | 2004-02-17 | 2005-09-08 | Leeflang Stephen A. | Variable steerable catheters and methods for using them |
US8021326B2 (en) | 2004-03-05 | 2011-09-20 | Hansen Medical, Inc. | Instrument driver for robotic catheter system |
US20050273095A1 (en) * | 2004-06-07 | 2005-12-08 | Scimed Life Systems, Inc. | Ablation catheters having anchoring capability and methods of using same |
WO2006014993A1 (en) | 2004-07-27 | 2006-02-09 | Medeikon Corporation | Device for tissue characterization |
US8208995B2 (en) | 2004-08-24 | 2012-06-26 | The General Hospital Corporation | Method and apparatus for imaging of vessel segments |
US20060069303A1 (en) | 2004-09-30 | 2006-03-30 | Couvillon Lucien A Jr | Endoscopic apparatus with integrated hemostasis device |
US8029470B2 (en) | 2004-09-30 | 2011-10-04 | Pacesetter, Inc. | Transmembrane access systems and methods |
US7875049B2 (en) | 2004-10-04 | 2011-01-25 | Medtronic, Inc. | Expandable guide sheath with steerable backbone and methods for making and using them |
US20060089637A1 (en) | 2004-10-14 | 2006-04-27 | Werneth Randell L | Ablation catheter |
MX2007005921A (en) | 2004-11-17 | 2007-10-08 | Johnson & Johnson | Apparatus for real time evaluation of tissue ablation. |
US7883503B2 (en) | 2005-01-26 | 2011-02-08 | Kalser Gary | Illuminating balloon catheter and method for using the catheter |
US10064540B2 (en) | 2005-02-02 | 2018-09-04 | Intuitive Surgical Operations, Inc. | Visualization apparatus for transseptal access |
US8078266B2 (en) | 2005-10-25 | 2011-12-13 | Voyage Medical, Inc. | Flow reduction hood systems |
US7860556B2 (en) | 2005-02-02 | 2010-12-28 | Voyage Medical, Inc. | Tissue imaging and extraction systems |
US7860555B2 (en) | 2005-02-02 | 2010-12-28 | Voyage Medical, Inc. | Tissue visualization and manipulation system |
WO2006091597A1 (en) | 2005-02-22 | 2006-08-31 | Cardiofocus, Inc. | Deflectable sheath catheters |
US7585308B2 (en) | 2005-03-30 | 2009-09-08 | Ethicon Endo-Surgery, Inc. | Handle system and method for use in anastomotic procedures |
US20060258909A1 (en) | 2005-04-08 | 2006-11-16 | Usgi Medical, Inc. | Methods and apparatus for maintaining sterility during transluminal procedures |
US20060271032A1 (en) | 2005-05-26 | 2006-11-30 | Chin Albert K | Ablation instruments and methods for performing abalation |
US7575569B2 (en) | 2005-08-16 | 2009-08-18 | Medtronic, Inc. | Apparatus and methods for delivering stem cells and other agents into cardiac tissue |
US7416552B2 (en) | 2005-08-22 | 2008-08-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Multipolar, multi-lumen, virtual-electrode catheter with at least one surface electrode and method for ablation |
US8355801B2 (en) | 2005-09-26 | 2013-01-15 | Biosense Webster, Inc. | System and method for measuring esophagus proximity |
US20070093804A1 (en) | 2005-10-17 | 2007-04-26 | Coaptus Medical Corporation | Control systems for patient devices, including devices for securing cardiovascular tissue, and associated methods |
US7918793B2 (en) | 2005-10-28 | 2011-04-05 | Biosense Webster, Inc. | Synchronization of ultrasound imaging data with electrical mapping |
US20070135826A1 (en) | 2005-12-01 | 2007-06-14 | Steve Zaver | Method and apparatus for delivering an implant without bias to a left atrial appendage |
US8303505B2 (en) | 2005-12-02 | 2012-11-06 | Abbott Cardiovascular Systems Inc. | Methods and apparatuses for image guided medical procedures |
US20090240248A1 (en) | 2005-12-30 | 2009-09-24 | C.R. Bard , Inc | Methods and Apparatus for Ablation of Cardiac Tissue |
JP5324422B2 (en) | 2006-03-20 | 2013-10-23 | メドトロニック,インコーポレイテッド | Removable valve and valve manufacturing method |
US20070270686A1 (en) | 2006-05-03 | 2007-11-22 | Ritter Rogers C | Apparatus and methods for using inertial sensing to navigate a medical device |
EP2540246B8 (en) | 2006-05-12 | 2020-10-07 | Vytronus, Inc. | Device for ablating body tissue |
US9220402B2 (en) | 2006-06-07 | 2015-12-29 | Intuitive Surgical Operations, Inc. | Visualization and treatment via percutaneous methods and devices |
US8189929B2 (en) | 2006-08-02 | 2012-05-29 | Koninklijke Philips Electronics N.V. | Method of rearranging a cluster map of voxels in an image |
US8409172B2 (en) | 2006-08-03 | 2013-04-02 | Hansen Medical, Inc. | Systems and methods for performing minimally invasive procedures |
WO2008024261A2 (en) | 2006-08-23 | 2008-02-28 | Cardio-Optics, Inc | Image-guided therapy of the fossa ovalis and septal defects |
US20080057106A1 (en) | 2006-08-29 | 2008-03-06 | Erickson Signe R | Low profile bioactive agent delivery device |
US10004388B2 (en) | 2006-09-01 | 2018-06-26 | Intuitive Surgical Operations, Inc. | Coronary sinus cannulation |
US20080097476A1 (en) | 2006-09-01 | 2008-04-24 | Voyage Medical, Inc. | Precision control systems for tissue visualization and manipulation assemblies |
EP2056707A4 (en) | 2006-09-01 | 2010-05-26 | Nidus Medical Llc | Tissue visualization device having multi-segmented frame |
US10335131B2 (en) | 2006-10-23 | 2019-07-02 | Intuitive Surgical Operations, Inc. | Methods for preventing tissue migration |
US20080183036A1 (en) | 2006-12-18 | 2008-07-31 | Voyage Medical, Inc. | Systems and methods for unobstructed visualization and ablation |
US8337518B2 (en) | 2006-12-20 | 2012-12-25 | Onset Medical Corporation | Expandable trans-septal sheath |
US8131350B2 (en) | 2006-12-21 | 2012-03-06 | Voyage Medical, Inc. | Stabilization of visualization catheters |
US8758229B2 (en) | 2006-12-21 | 2014-06-24 | Intuitive Surgical Operations, Inc. | Axial visualization systems |
EP2148608A4 (en) | 2007-04-27 | 2010-04-28 | Voyage Medical Inc | Complex shape steerable tissue visualization and manipulation catheter |
US8657805B2 (en) | 2007-05-08 | 2014-02-25 | Intuitive Surgical Operations, Inc. | Complex shape steerable tissue visualization and manipulation catheter |
US8527032B2 (en) | 2007-05-16 | 2013-09-03 | General Electric Company | Imaging system and method of delivery of an instrument to an imaged subject |
US20080287805A1 (en) | 2007-05-16 | 2008-11-20 | General Electric Company | System and method to guide an instrument through an imaged subject |
WO2008154007A1 (en) | 2007-06-08 | 2008-12-18 | Cynosure, Inc. | Surgical waveguide |
US8235985B2 (en) | 2007-08-31 | 2012-08-07 | Voyage Medical, Inc. | Visualization and ablation system variations |
US20090062790A1 (en) | 2007-08-31 | 2009-03-05 | Voyage Medical, Inc. | Direct visualization bipolar ablation systems |
US20090125022A1 (en) | 2007-11-12 | 2009-05-14 | Voyage Medical, Inc. | Tissue visualization and ablation systems |
US20090143640A1 (en) | 2007-11-26 | 2009-06-04 | Voyage Medical, Inc. | Combination imaging and treatment assemblies |
WO2009092021A1 (en) | 2008-01-17 | 2009-07-23 | Nidus Medical, Llc | Epicardial access and treatment systems |
US8858609B2 (en) | 2008-02-07 | 2014-10-14 | Intuitive Surgical Operations, Inc. | Stent delivery under direct visualization |
WO2009112262A2 (en) | 2008-03-12 | 2009-09-17 | Afreeze Gmbh | Handle for an ablation device |
US8532734B2 (en) | 2008-04-18 | 2013-09-10 | Regents Of The University Of Minnesota | Method and apparatus for mapping a structure |
US8494608B2 (en) | 2008-04-18 | 2013-07-23 | Medtronic, Inc. | Method and apparatus for mapping a structure |
US20090326572A1 (en) | 2008-06-27 | 2009-12-31 | Ruey-Feng Peh | Apparatus and methods for rapid tissue crossing |
US8333012B2 (en) | 2008-10-10 | 2012-12-18 | Voyage Medical, Inc. | Method of forming electrode placement and connection systems |
US9468364B2 (en) | 2008-11-14 | 2016-10-18 | Intuitive Surgical Operations, Inc. | Intravascular catheter with hood and image processing systems |
US20110144576A1 (en) | 2009-12-14 | 2011-06-16 | Voyage Medical, Inc. | Catheter orientation control system mechanisms |
US9814522B2 (en) | 2010-04-06 | 2017-11-14 | Intuitive Surgical Operations, Inc. | Apparatus and methods for ablation efficacy |
-
2007
- 2007-12-18 US US11/959,158 patent/US20080183036A1/en not_active Abandoned
-
2016
- 2016-02-16 US US15/044,667 patent/US10441136B2/en active Active
Patent Citations (104)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3559651A (en) * | 1968-10-14 | 1971-02-02 | David H Moss | Body-worn all disposable urinal |
US4576146A (en) * | 1983-03-22 | 1986-03-18 | Sumitomo Electric Industries, Ltd. | Fiberscope |
US4569335A (en) * | 1983-04-12 | 1986-02-11 | Sumitomo Electric Industries, Ltd. | Fiberscope |
US4611594A (en) * | 1984-04-11 | 1986-09-16 | Northwestern University | Medical instrument for containment and removal of calculi |
US4727418A (en) * | 1985-07-02 | 1988-02-23 | Olympus Optical Co., Ltd. | Image processing apparatus |
US5090959A (en) * | 1987-04-30 | 1992-02-25 | Advanced Cardiovascular Systems, Inc. | Imaging balloon dilatation catheter |
US4998972A (en) * | 1988-04-28 | 1991-03-12 | Thomas J. Fogarty | Real time angioscopy imaging system |
US4994069A (en) * | 1988-11-02 | 1991-02-19 | Target Therapeutics | Vaso-occlusion coil and method |
US4998916A (en) * | 1989-01-09 | 1991-03-12 | Hammerslag Julius G | Steerable medical device |
US4911148A (en) * | 1989-03-14 | 1990-03-27 | Intramed Laboratories, Inc. | Deflectable-end endoscope with detachable flexible shaft assembly |
US4991578A (en) * | 1989-04-04 | 1991-02-12 | Siemens-Pacesetter, Inc. | Method and system for implanting self-anchoring epicardial defibrillation electrodes |
US5593422A (en) * | 1989-05-29 | 1997-01-14 | Muijs Van De Moer; Wouter M. | Occlusion assembly for sealing openings in blood vessels and a method for sealing openings in blood vessels |
US5282827A (en) * | 1991-11-08 | 1994-02-01 | Kensey Nash Corporation | Hemostatic puncture closure system and method of use |
US5281238A (en) * | 1991-11-22 | 1994-01-25 | Chin Albert K | Endoscopic ligation instrument |
US5336252A (en) * | 1992-06-22 | 1994-08-09 | Cohen Donald M | System and method for implanting cardiac electrical leads |
US6168594B1 (en) * | 1992-11-13 | 2001-01-02 | Scimed Life Systems, Inc. | Electrophysiology RF energy treatment device |
US5860991A (en) * | 1992-12-10 | 1999-01-19 | Perclose, Inc. | Method for the percutaneous suturing of a vascular puncture site |
US5496330A (en) * | 1993-02-19 | 1996-03-05 | Boston Scientific Corporation | Surgical extractor with closely angularly spaced individual filaments |
US5860974A (en) * | 1993-07-01 | 1999-01-19 | Boston Scientific Corporation | Heart ablation catheter with expandable electrode and method of coupling energy to an electrode on a catheter shaft |
US5713946A (en) * | 1993-07-20 | 1998-02-03 | Biosense, Inc. | Apparatus and method for intrabody mapping |
US5385148A (en) * | 1993-07-30 | 1995-01-31 | The Regents Of The University Of California | Cardiac imaging and ablation catheter |
US5391182A (en) * | 1993-08-03 | 1995-02-21 | Origin Medsystems, Inc. | Apparatus and method for closing puncture wounds |
US5593405A (en) * | 1994-07-16 | 1997-01-14 | Osypka; Peter | Fiber optic endoscope |
US5593424A (en) * | 1994-08-10 | 1997-01-14 | Segmed, Inc. | Apparatus and method for reducing and stabilizing the circumference of a vascular structure |
US6168591B1 (en) * | 1994-09-09 | 2001-01-02 | Cardiofocus, Inc. | Guide for penetrating phototherapy |
US6676656B2 (en) * | 1994-09-09 | 2004-01-13 | Cardiofocus, Inc. | Surgical ablation with radiant energy |
US20040006333A1 (en) * | 1994-09-09 | 2004-01-08 | Cardiofocus, Inc. | Coaxial catheter instruments for ablation with radiant energy |
US20050038419A9 (en) * | 1994-09-09 | 2005-02-17 | Cardiofocus, Inc. | Coaxial catheter instruments for ablation with radiant energy |
US5498230A (en) * | 1994-10-03 | 1996-03-12 | Adair; Edwin L. | Sterile connector and video camera cover for sterile endoscope |
US5591119A (en) * | 1994-12-07 | 1997-01-07 | Adair; Edwin L. | Sterile surgical coupler and drape |
US20080015563A1 (en) * | 1995-02-22 | 2008-01-17 | Hoey Michael F | Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue |
US5709224A (en) * | 1995-06-07 | 1998-01-20 | Radiotherapeutics Corporation | Method and device for permanent vessel occlusion |
US5865791A (en) * | 1995-06-07 | 1999-02-02 | E.P. Technologies Inc. | Atrial appendage stasis reduction procedure and devices |
US6190381B1 (en) * | 1995-06-07 | 2001-02-20 | Arthrocare Corporation | Methods for tissue resection, ablation and aspiration |
US6027501A (en) * | 1995-06-23 | 2000-02-22 | Gyrus Medical Limited | Electrosurgical instrument |
US5713907A (en) * | 1995-07-20 | 1998-02-03 | Endotex Interventional Systems, Inc. | Apparatus and method for dilating a lumen and for inserting an intraluminal graft |
US5873815A (en) * | 1995-10-10 | 1999-02-23 | Conceptus, Inc. | Access catheter and method for maintaining separation between a falloposcope and a tubal wall |
US5716321A (en) * | 1995-10-10 | 1998-02-10 | Conceptus, Inc. | Method for maintaining separation between a falloposcope and a tubal wall |
US6174307B1 (en) * | 1996-03-29 | 2001-01-16 | Eclipse Surgical Technologies, Inc. | Viewing surgical scope for minimally invasive procedures |
US5725523A (en) * | 1996-03-29 | 1998-03-10 | Mueller; Richard L. | Lateral-and posterior-aspect method and apparatus for laser-assisted transmyocardial revascularization and other surgical applications |
US6840936B2 (en) * | 1996-10-22 | 2005-01-11 | Epicor Medical, Inc. | Methods and devices for ablation |
US6858026B2 (en) * | 1996-10-22 | 2005-02-22 | Epicor Medical, Inc. | Methods and devices for ablation |
US6689128B2 (en) * | 1996-10-22 | 2004-02-10 | Epicor Medical, Inc. | Methods and devices for ablation |
US5722403A (en) * | 1996-10-28 | 1998-03-03 | Ep Technologies, Inc. | Systems and methods using a porous electrode for ablating and visualizing interior tissue regions |
US5879366A (en) * | 1996-12-20 | 1999-03-09 | W.L. Gore & Associates, Inc. | Self-expanding defect closure device and method of making and using |
US20020026145A1 (en) * | 1997-03-06 | 2002-02-28 | Bagaoisan Celso J. | Method and apparatus for emboli containment |
US6502576B1 (en) * | 1997-07-08 | 2003-01-07 | The Regents Of The University Of California | Device and method for forming a circumferential conduction block in a pulmonary vein |
US6514249B1 (en) * | 1997-07-08 | 2003-02-04 | Atrionix, Inc. | Positioning system and method for orienting an ablation element within a pulmonary vein ostium |
US6024740A (en) * | 1997-07-08 | 2000-02-15 | The Regents Of The University Of California | Circumferential ablation device assembly |
US6012457A (en) * | 1997-07-08 | 2000-01-11 | The Regents Of The University Of California | Device and method for forming a circumferential conduction block in a pulmonary vein |
US6517533B1 (en) * | 1997-07-29 | 2003-02-11 | M. J. Swaminathan | Balloon catheter for controlling tissue remodeling and/or tissue proliferation |
US6682526B1 (en) * | 1997-09-11 | 2004-01-27 | Vnus Medical Technologies, Inc. | Expandable catheter having two sets of electrodes, and method of use |
US7041098B2 (en) * | 1997-09-11 | 2006-05-09 | Vnus Medical Technologies, Inc. | Expandable vein ligator catheter and method of use |
US20060022234A1 (en) * | 1997-10-06 | 2006-02-02 | Adair Edwin L | Reduced area imaging device incorporated within wireless endoscopic devices |
US6982740B2 (en) * | 1997-11-24 | 2006-01-03 | Micro-Medical Devices, Inc. | Reduced area imaging devices utilizing selected charge integration periods |
US7169144B2 (en) * | 1998-07-07 | 2007-01-30 | Medtronic, Inc. | Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue |
US7156845B2 (en) * | 1998-07-07 | 2007-01-02 | Medtronic, Inc. | Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue |
US6849073B2 (en) * | 1998-07-07 | 2005-02-01 | Medtronic, Inc. | Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue |
US6178346B1 (en) * | 1998-10-23 | 2001-01-23 | David C. Amundson | Infrared endoscopic imaging in a liquid with suspended particles: method and apparatus |
US6840923B1 (en) * | 1999-06-24 | 2005-01-11 | Colocare Holdings Pty Limited | Colostomy pump device |
US6673090B2 (en) * | 1999-08-04 | 2004-01-06 | Scimed Life Systems, Inc. | Percutaneous catheter and guidewire for filtering during ablation of myocardial or vascular tissue |
US20020004644A1 (en) * | 1999-11-22 | 2002-01-10 | Scimed Life Systems, Inc. | Methods of deploying helical diagnostic and therapeutic element supporting structures within the body |
US6858005B2 (en) * | 2000-04-03 | 2005-02-22 | Neo Guide Systems, Inc. | Tendon-driven endoscope and methods of insertion |
US6692430B2 (en) * | 2000-04-10 | 2004-02-17 | C2Cure Inc. | Intra vascular imaging apparatus |
US20060009715A1 (en) * | 2000-04-13 | 2006-01-12 | Khairkhahan Alexander K | Method and apparatus for accessing the left atrial appendage |
US20050125024A1 (en) * | 2000-06-29 | 2005-06-09 | Concentric Medical, Inc., A Delaware Corporation | Systems, methods and devices for removing obstructions from a blood vessel |
US20030009085A1 (en) * | 2001-06-04 | 2003-01-09 | Olympus Optical Co., Ltd. | Treatment apparatus for endoscope |
US20030035156A1 (en) * | 2001-08-15 | 2003-02-20 | Sony Corporation | System and method for efficiently performing a white balance operation |
US20030036698A1 (en) * | 2001-08-16 | 2003-02-20 | Robert Kohler | Interventional diagnostic catheter and a method for using a catheter to access artificial cardiac shunts |
US20050014995A1 (en) * | 2001-11-09 | 2005-01-20 | David Amundson | Direct, real-time imaging guidance of cardiac catheterization |
US7166537B2 (en) * | 2002-03-18 | 2007-01-23 | Sarcos Investments Lc | Miniaturized imaging device with integrated circuit connector system |
US20070015964A1 (en) * | 2002-05-30 | 2007-01-18 | Eversull Christian S | Apparatus and Methods for Coronary Sinus Access |
US20060025787A1 (en) * | 2002-06-13 | 2006-02-02 | Guided Delivery Systems, Inc. | Devices and methods for heart valve repair |
US6679836B2 (en) * | 2002-06-21 | 2004-01-20 | Scimed Life Systems, Inc. | Universal programmable guide catheter |
US20050020914A1 (en) * | 2002-11-12 | 2005-01-27 | David Amundson | Coronary sinus access catheter with forward-imaging |
US6984232B2 (en) * | 2003-01-17 | 2006-01-10 | St. Jude Medical, Daig Division, Inc. | Ablation catheter assembly having a virtual electrode comprising portholes |
US20080009859A1 (en) * | 2003-02-13 | 2008-01-10 | Coaptus Medical Corporation | Transseptal left atrial access and septal closure |
US20050015048A1 (en) * | 2003-03-12 | 2005-01-20 | Chiu Jessica G. | Infusion treatment agents, catheters, filter devices, and occlusion devices, and use thereof |
US20050124969A1 (en) * | 2003-03-18 | 2005-06-09 | Fitzgerald Peter J. | Methods and devices for retrieval of a medical agent from a physiological efferent fluid collection site |
US6994094B2 (en) * | 2003-04-29 | 2006-02-07 | Biosense, Inc. | Method and device for transseptal facilitation based on injury patterns |
US20050027163A1 (en) * | 2003-07-29 | 2005-02-03 | Scimed Life Systems, Inc. | Vision catheter |
US7163534B2 (en) * | 2003-10-30 | 2007-01-16 | Medical Cv, Inc. | Laser-based maze procedure for atrial fibrillation |
US20070043338A1 (en) * | 2004-03-05 | 2007-02-22 | Hansen Medical, Inc | Robotic catheter system and methods |
US20060015096A1 (en) * | 2004-05-28 | 2006-01-19 | Hauck John A | Radio frequency ablation servo catheter and method |
US20060009737A1 (en) * | 2004-07-12 | 2006-01-12 | Whiting James S | Methods and devices for transseptal access |
US20060025651A1 (en) * | 2004-07-29 | 2006-02-02 | Doron Adler | Endoscope electronics assembly |
US20060030844A1 (en) * | 2004-08-04 | 2006-02-09 | Knight Bradley P | Transparent electrode for the radiofrequency ablation of tissue |
US20080015569A1 (en) * | 2005-02-02 | 2008-01-17 | Voyage Medical, Inc. | Methods and apparatus for treatment of atrial fibrillation |
US20080009747A1 (en) * | 2005-02-02 | 2008-01-10 | Voyage Medical, Inc. | Transmural subsurface interrogation and ablation |
US20080015445A1 (en) * | 2005-02-02 | 2008-01-17 | Voyage Medical, Inc. | Tissue visualization device and method variations |
US20090054803A1 (en) * | 2005-02-02 | 2009-02-26 | Vahid Saadat | Electrophysiology mapping and visualization system |
US20100004506A1 (en) * | 2005-02-02 | 2010-01-07 | Voyage Medical, Inc. | Tissue visualization and manipulation systems |
US20070016130A1 (en) * | 2005-05-06 | 2007-01-18 | Leeflang Stephen A | Complex Shaped Steerable Catheters and Methods for Making and Using Them |
US20070005019A1 (en) * | 2005-06-24 | 2007-01-04 | Terumo Kabushiki Kaisha | Catheter assembly |
US20070043413A1 (en) * | 2005-08-16 | 2007-02-22 | Eversull Christian S | Apparatus and methods for delivering transvenous leads |
US20080033290A1 (en) * | 2005-10-25 | 2008-02-07 | Voyage Medical, Inc. | Delivery of biological compounds to ischemic and/or infarcted tissue |
US20100010311A1 (en) * | 2005-10-25 | 2010-01-14 | Voyage Medical, Inc. | Methods and apparatus for efficient purging |
US20100004661A1 (en) * | 2006-07-12 | 2010-01-07 | Les Hopitaux Universitaires De Geneve | Medical device for tissue ablation |
US20080027464A1 (en) * | 2006-07-26 | 2008-01-31 | Moll Frederic H | Systems and methods for performing minimally invasive surgical operations |
US20080033241A1 (en) * | 2006-08-01 | 2008-02-07 | Ruey-Feng Peh | Left atrial appendage closure |
US20090030412A1 (en) * | 2007-05-11 | 2009-01-29 | Willis N Parker | Visual electrode ablation systems |
US20090030276A1 (en) * | 2007-07-27 | 2009-01-29 | Voyage Medical, Inc. | Tissue visualization catheter with imaging systems integration |
US20100004633A1 (en) * | 2008-07-07 | 2010-01-07 | Voyage Medical, Inc. | Catheter control systems |
US20120016221A1 (en) * | 2010-02-12 | 2012-01-19 | Voyage Medical, Inc. | Image stabilization techniques and methods |
Cited By (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10441136B2 (en) | 2006-12-18 | 2019-10-15 | Intuitive Surgical Operations, Inc. | Systems and methods for unobstructed visualization and ablation |
US10058380B2 (en) | 2007-10-05 | 2018-08-28 | Maquet Cordiovascular Llc | Devices and methods for minimally-invasive surgical procedures |
US10993766B2 (en) | 2007-10-05 | 2021-05-04 | Maquet Cardiovascular Llc | Devices and methods for minimally-invasive surgical procedures |
US11779430B2 (en) * | 2008-10-06 | 2023-10-10 | Santa Anna Tech Llc | Vapor based ablation system for treating uterine bleeding |
US10842549B2 (en) | 2008-10-06 | 2020-11-24 | Santa Anna Tech Llc | Vapor ablation system with a catheter having more than one positioning element and configured to treat pulmonary tissue |
US11813014B2 (en) | 2008-10-06 | 2023-11-14 | Santa Anna Tech Llc | Methods and systems for directed tissue ablation |
US10842557B2 (en) | 2008-10-06 | 2020-11-24 | Santa Anna Tech Llc | Vapor ablation system with a catheter having more than one positioning element and configured to treat duodenal tissue |
US10842548B2 (en) | 2008-10-06 | 2020-11-24 | Santa Anna Tech Llc | Vapor ablation system with a catheter having more than one positioning element |
US10695126B2 (en) | 2008-10-06 | 2020-06-30 | Santa Anna Tech Llc | Catheter with a double balloon structure to generate and apply a heated ablative zone to tissue |
US9561067B2 (en) * | 2008-10-06 | 2017-02-07 | Virender K. Sharma | Method and apparatus for tissue ablation |
US11589920B2 (en) | 2008-10-06 | 2023-02-28 | Santa Anna Tech Llc | Catheter with a double balloon structure to generate and apply an ablative zone to tissue |
US20190133712A1 (en) * | 2008-10-06 | 2019-05-09 | Santa Anna Tech Llc | Vapor Based Ablation System for Treating Various Indications |
US20140200568A1 (en) * | 2008-10-06 | 2014-07-17 | Virender K. Sharma | Method and Apparatus for Tissue Ablation |
US10064697B2 (en) | 2008-10-06 | 2018-09-04 | Santa Anna Tech Llc | Vapor based ablation system for treating various indications |
US11020175B2 (en) | 2008-10-06 | 2021-06-01 | Santa Anna Tech Llc | Methods of ablating tissue using time-limited treatment periods |
US20100191232A1 (en) * | 2009-01-27 | 2010-07-29 | Boveda Marco Medical Llc | Catheters and methods for performing electrophysiological interventions |
WO2010088301A1 (en) * | 2009-01-27 | 2010-08-05 | Boveda Marco Medical Llc | Catheters and methods for performing electrophysiological interventions |
US8728011B2 (en) | 2011-07-22 | 2014-05-20 | Michael D. Khoury | Multi wire sheath |
US11559192B2 (en) | 2011-09-22 | 2023-01-24 | The George Washington University | Systems and methods for visualizing ablated tissue |
US10076238B2 (en) | 2011-09-22 | 2018-09-18 | The George Washington University | Systems and methods for visualizing ablated tissue |
US9014789B2 (en) | 2011-09-22 | 2015-04-21 | The George Washington University | Systems and methods for visualizing ablated tissue |
US10716462B2 (en) | 2011-09-22 | 2020-07-21 | The George Washington University | Systems and methods for visualizing ablated tissue |
US9084611B2 (en) | 2011-09-22 | 2015-07-21 | The George Washington University | Systems and methods for visualizing ablated tissue |
US10736512B2 (en) | 2011-09-22 | 2020-08-11 | The George Washington University | Systems and methods for visualizing ablated tissue |
US10342608B2 (en) | 2012-10-18 | 2019-07-09 | The Board Of Trustees Of The Leland Stanford Junior University | Ablation catheter system and method for deploying same |
US20160256216A1 (en) * | 2013-03-11 | 2016-09-08 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses for pulmonary artery neuromodulation |
US11096584B2 (en) | 2013-11-14 | 2021-08-24 | The George Washington University | Systems and methods for determining lesion depth using fluorescence imaging |
US11457817B2 (en) | 2013-11-20 | 2022-10-04 | The George Washington University | Systems and methods for hyperspectral analysis of cardiac tissue |
US10716477B2 (en) | 2014-01-07 | 2020-07-21 | Kardium Inc. | Medical device including manipulable portion with connected elongate members |
US10278590B2 (en) | 2014-01-07 | 2019-05-07 | Kardium Inc. | Medical device including manipulable portion with connected elongate members |
US20150190616A1 (en) * | 2014-01-07 | 2015-07-09 | Aldo Antonio Salvestro | Medical device including manipulable portion with connected elongate members |
US9993160B2 (en) * | 2014-01-07 | 2018-06-12 | Kardium Inc. | Medical device including manipulable portion with connected elongate members |
US11033191B2 (en) | 2014-01-07 | 2021-06-15 | Kardium Inc. | Medical device including manipulable portion with connected elongate members |
US20170119489A1 (en) * | 2014-06-17 | 2017-05-04 | Tau Pnu Medical Co., Ltd. | Tissue protection device for tricuspid regurgitation surgery |
US10973524B2 (en) * | 2014-06-17 | 2021-04-13 | Tau-Pnu Medical Co., Ltd. | Device for transcatheter treatment for tricuspid regurgitation |
US20160089172A1 (en) * | 2014-09-30 | 2016-03-31 | Boston Scientific Scimed, Inc. | Devices and methods for applying suction |
US11305096B2 (en) | 2014-10-30 | 2022-04-19 | Kardium Inc. | Catheter system |
US11559352B2 (en) | 2014-11-03 | 2023-01-24 | The George Washington University | Systems and methods for lesion assessment |
US10722301B2 (en) | 2014-11-03 | 2020-07-28 | The George Washington University | Systems and methods for lesion assessment |
US11596472B2 (en) | 2014-11-03 | 2023-03-07 | 460Medical, Inc. | Systems and methods for assessment of contact quality |
US10682179B2 (en) | 2014-11-03 | 2020-06-16 | 460Medical, Inc. | Systems and methods for determining tissue type |
US10143517B2 (en) | 2014-11-03 | 2018-12-04 | LuxCath, LLC | Systems and methods for assessment of contact quality |
US11154351B2 (en) * | 2014-11-14 | 2021-10-26 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses for modulation of nerves in communication with the pulmonary system and associated systems and methods |
US10779904B2 (en) | 2015-07-19 | 2020-09-22 | 460Medical, Inc. | Systems and methods for lesion formation and assessment |
EP3328293A4 (en) * | 2015-07-31 | 2019-11-27 | University of Utah Research Foundation | Devices, systems, and methods for imaging and treating a selected tissue |
US11154186B2 (en) | 2015-07-31 | 2021-10-26 | University Of Utah Research Foundation | Devices, systems, and methods for imaging and treating a selected tissue |
CN109310283A (en) * | 2016-04-19 | 2019-02-05 | 波士顿科学国际有限公司 | Foley's tube visualization device including reinforcing element |
US11331140B2 (en) | 2016-05-19 | 2022-05-17 | Aqua Heart, Inc. | Heated vapor ablation systems and methods for treating cardiac conditions |
US11602270B2 (en) | 2017-02-01 | 2023-03-14 | University Of Utah Research Foundation | Devices and methods for mapping cardiac tissue |
US11723518B2 (en) * | 2017-10-25 | 2023-08-15 | Boston Scientific Scimed, Inc. | Direct visualization catheter and system |
US11806066B2 (en) | 2018-06-01 | 2023-11-07 | Santa Anna Tech Llc | Multi-stage vapor-based ablation treatment methods and vapor generation and delivery systems |
US11864809B2 (en) | 2018-06-01 | 2024-01-09 | Santa Anna Tech Llc | Vapor-based ablation treatment methods with improved treatment volume vapor management |
Also Published As
Publication number | Publication date |
---|---|
US20160157702A1 (en) | 2016-06-09 |
US10441136B2 (en) | 2019-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10441136B2 (en) | Systems and methods for unobstructed visualization and ablation | |
US11559188B2 (en) | Off-axis visualization systems | |
US9526401B2 (en) | Flow reduction hood systems | |
US11337594B2 (en) | Coronary sinus cannulation | |
US11478152B2 (en) | Electrophysiology mapping and visualization system | |
US8131350B2 (en) | Stabilization of visualization catheters | |
US20190021577A1 (en) | Complex shape steerable tissue visualization and manipulation catheter | |
US9155452B2 (en) | Complex shape steerable tissue visualization and manipulation catheter | |
US8419613B2 (en) | Tissue visualization device | |
US9192287B2 (en) | Tissue visualization device and method variations | |
US7860556B2 (en) | Tissue imaging and extraction systems | |
EP1845854B1 (en) | Tissue visualization and manipulation system | |
US9220402B2 (en) | Visualization and treatment via percutaneous methods and devices | |
US20080033241A1 (en) | Left atrial appendage closure |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: VOYAGE MEDICAL, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SAADAT, VAHID;ROTHE, CHRIS A.;PEH, RUEY-FENG;AND OTHERS;REEL/FRAME:020264/0571 Effective date: 20071029 |
|
AS | Assignment |
Owner name: TRIPLEPOINT CAPITAL LLC, CALIFORNIA Free format text: SECURITY AGREEMENT;ASSIGNOR:VOYAGE MEDICAL, INC.;REEL/FRAME:029011/0077 Effective date: 20120921 |
|
AS | Assignment |
Owner name: INTUITIVE SURGICAL OPERATIONS, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VOYAGE MEDICAL, INC.;REEL/FRAME:031030/0061 Effective date: 20130816 Owner name: VOYAGE MEDICAL, INC., CALIFORNIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:TRIPLEPOINT CAPITAL LLC;REEL/FRAME:031029/0949 Effective date: 20130816 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |